data_1bh4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bh4 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.58 -88.05 0.08 OUTLIER Glycine 0 N--CA 1.485 1.946 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 174.91 -171.77 0.06 Allowed 'General case' 0 N--CA 1.503 2.202 0 O-C-N 124.867 0.98 . . . . 0.0 112.147 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.458 ' H ' ' HG ' ' A' ' 4' ' ' SER . 4.1 m -49.63 147.85 3.29 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.552 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 0.8 OUTLIER -127.54 36.49 4.37 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 112.077 -2.329 . . . . 0.0 110.484 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.0 t -66.69 -59.69 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.4 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 46.5 t-105 -67.79 -51.15 52.18 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.936 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -132.35 152.97 81.01 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 124.546 1.154 . . . . 0.0 110.546 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -74.41 167.95 25.94 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.854 2.369 . . . . 0.0 110.877 172.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -86.77 177.74 7.22 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.327 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.95 -74.77 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.5 m -63.6 -42.11 98.28 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.16 11.31 4.31 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.857 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.93 -51.07 5.24 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.3 -66.3 0.64 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.488 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.93 -75.39 0.31 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.05 -172.49 1.67 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.3 m -148.92 139.46 22.58 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.623 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.414 ' HB2' ' SG ' ' A' ' 10' ' ' CYS . 10.2 t -81.27 114.62 20.19 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.178 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -147.05 135.71 22.04 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.131 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.9 t30 48.98 68.16 0.76 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 124.525 1.14 . . . . 0.0 110.665 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? 38.33 42.25 0.51 Allowed 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.41 HG11 ' CG ' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -151.02 135.14 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.633 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.552 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 50.7 m -99.88 56.12 0.96 Allowed 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.444 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 10.4 m-30 -99.49 167.88 10.33 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.384 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -94.13 40.72 1.08 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 56.18 39.84 30.21 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.936 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.79 -34.26 0.19 Allowed Glycine 0 N--CA 1.488 2.143 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.875 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.8 tt -113.35 138.17 22.35 Favored Pre-proline 0 N--CA 1.498 1.972 0 CA-C-O 119.256 -0.402 . . . . 0.0 110.827 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.444 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 4.4 Cg_endo . . . . . 0 C--N 1.317 -1.113 0 C-N-CA 121.614 1.543 . . . . 0.0 109.353 171.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.98 -90.48 0.08 OUTLIER Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 172.02 -165.38 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 125.203 1.179 . . . . 0.0 110.248 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.1 m -41.61 146.43 0.23 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.85 34.79 1.58 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 111.647 -2.524 . . . . 0.0 108.218 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.5 t -70.16 -60.84 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.599 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -64.57 -49.88 69.45 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.297 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 pp -132.39 161.82 60.79 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 124.643 1.214 . . . . 0.0 110.722 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -66.34 152.54 80.77 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.32 2.013 . . . . 0.0 109.841 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.04 166.14 18.72 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 123.921 0.763 . . . . 0.0 112.207 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.0 mm -89.88 -36.91 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.88 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.413 ' C ' ' H ' ' A' ' 14' ' ' ALA . 32.6 t -80.13 -110.78 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.585 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 60.14 -2.18 0.16 Allowed 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.413 ' H ' ' C ' ' A' ' 12' ' ' SER . . . -75.64 -32.62 60.3 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 123.486 0.491 . . . . 0.0 111.603 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.3 mp -56.48 -36.75 69.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 124.161 0.913 . . . . 0.0 110.838 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.29 1.16 0.68 Allowed Glycine 0 N--CA 1.487 2.083 0 CA-C-N 114.205 -1.362 . . . . 0.0 109.939 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.29 150.49 43.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 123.933 0.431 . . . . 0.0 111.863 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.7 m -133.3 131.01 39.68 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.264 -1.335 . . . . 0.0 107.824 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.2 t -71.32 121.63 18.84 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.608 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.472 ' HZ3' ' H ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -157.63 145.71 18.98 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 113.859 -1.519 . . . . 0.0 108.466 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.0 m120 52.38 56.4 7.75 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 124.22 0.95 . . . . 0.0 109.857 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 pttt 38.44 39.5 0.3 Allowed 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 113.538 -1.665 . . . . 0.0 114.825 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -150.3 143.98 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 36.4 t -102.68 67.22 0.98 Allowed 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.77 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.462 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 14.7 m-30 -109.56 169.4 8.73 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.797 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 -98.97 39.24 1.29 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.472 ' H ' ' HZ3' ' A' ' 20' ' ' LYS . 1.8 t30 55.9 44.05 26.44 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 113.398 -1.728 . . . . 0.0 110.519 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 165.41 -32.31 0.23 Allowed Glycine 0 N--CA 1.489 2.209 0 CA-C-N 114.843 -1.071 . . . . 0.0 113.481 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.1 tt -112.76 136.16 21.6 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 123.899 0.411 . . . . 0.0 110.058 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.462 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 9.8 Cg_endo . . . . . 0 C--N 1.314 -1.248 0 C-N-CA 121.625 1.55 . . . . 0.0 108.575 170.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.42 -88.55 0.07 OUTLIER Glycine 0 N--CA 1.483 1.821 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 174.79 -166.34 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.91 1.006 . . . . 0.0 110.892 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.9 m -42.57 146.52 0.34 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -135.11 44.78 2.57 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 111.266 -2.697 . . . . 0.0 108.113 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.8 t -80.55 -66.28 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 114.222 -1.354 . . . . 0.0 109.428 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 28.0 t-105 -67.04 -45.47 77.35 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.353 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.73 165.57 14.91 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 124.446 1.092 . . . . 0.0 109.607 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -74.86 -172.22 1.18 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.557 2.171 . . . . 0.0 109.802 165.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 37.4 m -76.22 -167.54 0.78 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.468 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.54 -57.58 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.449 ' C ' ' H ' ' A' ' 14' ' ' ALA . 68.9 m -59.27 -83.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.894 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 67.91 -15.12 0.21 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 123.879 0.737 . . . . 0.0 112.76 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' A' ' 12' ' ' SER . . . -67.81 -34.78 77.41 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mt -67.37 -5.4 14.34 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.586 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.1 23.82 53.94 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.39 160.53 32.19 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.332 0.586 . . . . 0.0 112.007 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.1 m -145.16 132.74 20.88 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.351 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.4 t -70.8 111.36 6.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 123.87 0.731 . . . . 0.0 110.564 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -138.54 130.56 28.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.365 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 t30 53.77 66.18 1.3 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 124.384 1.052 . . . . 0.0 111.355 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt 36.27 38.88 0.07 Allowed 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 114.057 -1.429 . . . . 0.0 114.71 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 t -150.4 136.04 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 49.3 t -103.98 80.95 1.8 Allowed 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.023 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.481 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 13.2 m-30 -114.45 169.76 8.81 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.159 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -95.03 42.11 1.09 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 55.86 41.51 29.98 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 113.913 -1.494 . . . . 0.0 111.51 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 162.27 -35.27 0.35 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.23 -0.986 . . . . 0.0 113.886 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.7 tt -110.12 138.95 20.95 Favored Pre-proline 0 N--CA 1.498 1.972 0 CA-C-O 119.227 -0.415 . . . . 0.0 110.094 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.481 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 7.7 Cg_endo . . . . . 0 C--N 1.314 -1.246 0 C-N-CA 121.408 1.405 . . . . 0.0 109.826 172.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.09 -87.25 0.06 OUTLIER Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 177.34 -165.78 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.551 0.795 . . . . 0.0 113.076 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.4 p -35.29 143.89 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 119.07 2.989 . . . . 0.0 119.07 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.8 m -110.82 19.3 18.71 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 110.831 -2.895 . . . . 0.0 110.166 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.0 t -79.3 -69.3 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-N 113.607 -1.633 . . . . 0.0 109.101 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -61.7 -38.33 87.44 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.964 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 tt -160.91 114.18 1.32 Allowed Pre-proline 0 N--CA 1.486 1.375 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.204 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.22 142.23 98.92 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.509 2.139 . . . . 0.0 110.229 166.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 p -66.12 176.55 1.68 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 114.805 -1.089 . . . . 0.0 112.594 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.73 -59.19 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.0 m -70.36 -53.24 17.42 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.338 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.08 -20.1 64.92 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.386 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.22 -27.77 68.23 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 123.804 0.69 . . . . 0.0 109.951 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mt -73.63 -56.18 5.34 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.78 -73.06 0.68 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.5 m -83.63 -176.79 6.46 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.535 -0.832 . . . . 0.0 109.892 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.6 m -128.67 168.88 15.15 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.719 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.0 m -104.53 99.98 9.66 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.15 140.66 47.72 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.399 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 48.64 58.32 5.38 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 124.179 0.924 . . . . 0.0 110.616 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.9 pttm 38.82 47.64 1.23 Allowed 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 114.031 -1.44 . . . . 0.0 113.665 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.455 HG11 ' CG ' ' A' ' 25' ' ' TYR . 0.4 OUTLIER -150.9 137.17 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 114.018 -1.446 . . . . 0.0 107.178 179.598 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 39.8 t -92.15 54.89 2.46 Favored 'General case' 0 N--CA 1.507 2.385 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.906 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.546 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 9.3 m-30 -108.91 161.76 14.83 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.328 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 -89.65 41.7 1.05 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 55.39 37.16 28.49 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.978 -1.465 . . . . 0.0 110.86 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 171.68 -27.46 0.1 Allowed Glycine 0 N--CA 1.488 2.107 0 CA-C-N 114.754 -1.112 . . . . 0.0 114.038 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.7 tt -120.44 129.15 25.46 Favored Pre-proline 0 N--CA 1.498 1.953 0 CA-C-N 117.375 0.588 . . . . 0.0 111.433 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.546 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 16.9 Cg_endo . . . . . 0 C--N 1.316 -1.138 0 C-N-CA 122.354 2.036 . . . . 0.0 112.07 177.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -141.43 -89.64 0.15 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 175.64 -163.56 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 124.709 0.888 . . . . 0.0 112.385 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -49.49 129.87 19.52 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-N 114.575 -1.193 . . . . 0.0 114.203 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.527 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 0.8 OUTLIER -102.13 34.45 2.71 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 112.896 -1.956 . . . . 0.0 109.146 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.9 t -75.7 -67.29 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.171 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -67.91 -41.25 82.96 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.033 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.1 tp -147.62 125.86 6.04 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 124.504 1.128 . . . . 0.0 109.789 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -72.01 150.13 54.06 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.472 2.114 . . . . 0.0 111.432 177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -72.78 154.17 40.78 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.566 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.8 mt -117.59 -48.91 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.5 m -62.19 -41.93 98.8 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.785 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.93 -24.5 38.35 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.338 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.19 -44.78 53.15 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 123.984 0.802 . . . . 0.0 110.453 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.7 mt -91.8 45.61 1.23 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 124.416 1.073 . . . . 0.0 108.356 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.36 -98.19 0.11 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.0 m -82.75 -164.11 0.81 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.15 0.5 . . . . 0.0 112.167 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.5 t -146.65 158.54 43.92 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.922 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 t -97.39 120.79 38.4 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.506 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -155.2 135.31 13.04 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.289 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.66 68.52 0.72 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.568 1.168 . . . . 0.0 110.681 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.3 pttm 37.09 44.04 0.37 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 113.897 -1.501 . . . . 0.0 114.919 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -151.27 131.69 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.934 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 5.5 m -95.46 42.85 1.09 Allowed 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.98 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.56 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 3.2 m-30 -104.62 162.59 13.14 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.52 33.99 0.9 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 113.618 -1.628 . . . . 0.0 108.298 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 52.63 43.91 30.69 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.188 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 176.59 -22.16 0.05 OUTLIER Glycine 0 N--CA 1.488 2.116 0 CA-C-N 114.714 -1.13 . . . . 0.0 113.978 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -145.01 129.58 9.0 Favored Pre-proline 0 N--CA 1.5 2.051 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.56 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 15.2 Cg_endo . . . . . 0 N--CA 1.485 1.021 0 C-N-CA 122.214 1.942 . . . . 0.0 113.004 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 26' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.52 -91.51 0.11 Allowed Glycine 0 N--CA 1.482 1.716 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 170.96 -167.66 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 124.828 0.957 . . . . 0.0 111.995 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.2 p -36.96 146.48 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.435 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -133.59 31.06 3.74 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 112.486 -2.143 . . . . 0.0 111.035 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.3 t -73.07 -49.72 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-N 114.27 -1.332 . . . . 0.0 108.891 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -71.73 -50.24 31.91 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.774 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 pt -144.13 132.01 10.76 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 124.385 1.053 . . . . 0.0 109.627 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -69.51 152.9 70.66 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.389 2.059 . . . . 0.0 111.873 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.49 148.22 51.8 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.334 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.5 mm -112.87 -56.49 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 124.302 1.001 . . . . 0.0 108.559 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 t -65.88 -42.59 90.11 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.068 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.97 -16.29 57.13 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 113.795 -1.548 . . . . 0.0 112.144 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.64 -45.78 14.18 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -83.84 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.599 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -53.37 -66.39 2.76 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -72.45 175.21 6.44 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 114.697 -0.752 . . . . 0.0 110.59 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.4 m -148.96 142.21 25.07 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.726 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 30.1 t -79.36 85.14 5.2 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.725 0.774 . . . . 0.0 109.899 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt -104.79 145.32 30.54 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.322 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.9 p30 39.78 56.03 2.42 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 124.61 1.194 . . . . 0.0 111.206 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt 41.18 44.11 2.11 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 113.234 -1.803 . . . . 0.0 113.627 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.1 t -150.21 134.09 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.435 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 51.5 m -92.04 73.47 5.55 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.826 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.454 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 11.9 m-30 -112.54 167.18 10.66 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 124.241 0.963 . . . . 0.0 109.867 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.4 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -117.15 89.51 3.13 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 62.29 51.57 3.39 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.11 -1.405 . . . . 0.0 110.118 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.64 -2.86 71.22 Favored Glycine 0 N--CA 1.492 2.373 0 CA-C-N 114.042 -1.436 . . . . 0.0 115.781 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.74 130.28 43.61 Favored Pre-proline 0 N--CA 1.501 2.102 0 CA-C-N 118.131 0.966 . . . . 0.0 108.485 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.454 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 4.5 Cg_endo . . . . . 0 N--CA 1.487 1.139 0 C-N-CA 121.637 1.558 . . . . 0.0 112.09 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.29 -85.81 0.06 OUTLIER Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 177.75 -168.82 0.07 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 124.706 0.886 . . . . 0.0 111.11 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.8 m -45.92 147.32 1.01 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -131.18 33.56 4.12 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 112.207 -2.27 . . . . 0.0 109.306 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.29 -58.34 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.263 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -67.09 -54.78 18.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.265 0.978 . . . . 0.0 110.736 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.73 147.62 42.91 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 124.525 1.14 . . . . 0.0 110.406 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -72.51 156.71 53.82 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.924 2.416 . . . . 0.0 111.346 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 p -75.06 146.58 41.39 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.311 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.9 mt -94.28 -49.12 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 124.284 0.99 . . . . 0.0 110.213 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.4 m -66.03 -56.29 12.33 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.31 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.46 -4.49 15.08 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.483 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.25 -48.55 79.45 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.131 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.9 mt -82.58 74.94 9.51 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.17 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.64 -66.47 0.37 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.211 -1.955 . . . . 0.0 108.211 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.5 162.16 19.05 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 114.164 -1.018 . . . . 0.0 110.08 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.8 m -136.78 132.85 35.31 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.412 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 53.9 t -69.65 131.25 44.32 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.281 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -159.45 127.75 5.03 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.11 -1.405 . . . . 0.0 107.912 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 50.47 76.34 0.15 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.345 1.028 . . . . 0.0 112.614 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt 35.6 40.58 0.08 Allowed 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.4 HG11 ' CG ' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -150.77 135.86 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.2 56.55 0.64 Allowed 'General case' 0 N--CA 1.507 2.425 0 CA-C-O 122.459 1.123 . . . . 0.0 108.407 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.441 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 10.8 m-30 -95.63 172.05 8.29 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 112.739 -2.028 . . . . 0.0 111.791 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -93.46 39.55 1.06 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 55.48 39.83 31.15 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 113.797 -1.547 . . . . 0.0 111.486 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 169.43 -34.88 0.18 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 120.248 -0.977 . . . . 0.0 114.037 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.9 tt -117.62 137.61 24.39 Favored Pre-proline 0 N--CA 1.497 1.909 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.562 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.441 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 7.8 Cg_endo . . . . . 0 N--CA 1.487 1.132 0 C-N-CA 121.728 1.619 . . . . 0.0 110.384 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.02 -84.6 0.05 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 175.73 -167.72 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 O-C-N 124.682 0.872 . . . . 0.0 110.727 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 p -44.59 141.89 1.85 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.22 34.76 4.83 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 112.039 -2.346 . . . . 0.0 109.105 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.9 t -79.73 -68.35 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.347 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 41.6 t-105 -60.22 -43.74 95.77 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.894 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.0 tp -153.61 122.22 3.12 Favored Pre-proline 0 N--CA 1.487 1.398 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.099 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -71.12 146.31 51.56 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.365 2.043 . . . . 0.0 111.313 174.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.2 p -69.13 149.11 49.02 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.09 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.1 mm -104.75 -43.79 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 124.469 1.106 . . . . 0.0 109.147 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.8 m -70.42 -57.57 4.67 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.014 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.11 -24.36 67.86 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.851 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.71 -27.87 30.64 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 123.484 0.49 . . . . 0.0 111.327 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 34.2 mt -67.53 -80.37 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 124.187 0.929 . . . . 0.0 110.02 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.4 -56.39 17.84 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.4 168.26 20.38 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.266 -0.967 . . . . 0.0 110.164 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.8 m -144.36 125.1 14.16 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.113 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 38.0 t -62.36 129.34 40.24 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.776 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.65 125.42 6.47 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.185 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 50.5 t30 49.08 73.88 0.21 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.58 1.175 . . . . 0.0 111.801 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt 36.01 47.49 0.44 Allowed 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.401 HG11 ' CG ' ' A' ' 25' ' ' TYR . 0.6 OUTLIER -150.99 130.9 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.39 45.8 0.95 Allowed 'General case' 0 N--CA 1.51 2.569 0 CA-C-O 122.44 1.114 . . . . 0.0 109.751 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.412 ' C ' ' H ' ' A' ' 27' ' ' ASN . 11.3 m-30 -90.2 169.63 10.98 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.06 -1.882 . . . . 0.0 110.859 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -90.71 36.85 0.9 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 25' ' ' TYR . 9.7 m120 52.13 40.79 29.41 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.042 -1.435 . . . . 0.0 110.345 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.35 -26.76 0.09 OUTLIER Glycine 0 N--CA 1.486 2.021 0 CA-C-N 114.387 -1.279 . . . . 0.0 113.483 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.1 tt -128.01 133.25 24.92 Favored Pre-proline 0 N--CA 1.497 1.884 0 CA-C-N 117.204 0.502 . . . . 0.0 110.249 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.4 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 9.7 Cg_endo . . . . . 0 N--CA 1.489 1.213 0 C-N-CA 121.847 1.698 . . . . 0.0 109.876 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.54 -91.1 0.09 OUTLIER Glycine 0 N--CA 1.482 1.74 0 N-CA-C 106.936 -2.466 . . . . 0.0 106.936 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 171.8 -159.35 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 125.167 1.157 . . . . 0.0 110.318 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.9 p -35.66 141.72 0.08 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.66 31.08 3.71 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 111.749 -2.478 . . . . 0.0 108.725 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.3 t -72.05 -63.64 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-N 113.752 -1.567 . . . . 0.0 110.483 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.9 t-105 -66.66 -47.63 71.9 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.998 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.06 162.96 53.61 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 124.479 1.112 . . . . 0.0 110.85 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -67.18 164.89 28.54 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.559 2.173 . . . . 0.0 111.056 172.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.73 171.27 14.65 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.215 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -95.93 -43.13 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.161 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 14' ' ' ALA . 39.7 t -73.84 -104.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.376 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 64.94 -9.47 0.19 Allowed 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.415 ' H ' ' C ' ' A' ' 12' ' ' SER . . . -66.79 -41.73 87.15 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 123.433 0.458 . . . . 0.0 109.922 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.1 mt -62.07 -33.2 73.96 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.167 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 128.08 27.13 0.95 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.6 m -65.15 109.79 2.31 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.336 0.588 . . . . 0.0 110.336 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.2 m -89.77 128.64 36.17 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 114.284 -1.325 . . . . 0.0 109.221 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 39.8 t -80.67 102.28 9.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 124.138 0.899 . . . . 0.0 110.599 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -138.06 145.98 42.41 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.889 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 50.23 57.53 6.48 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.461 1.1 . . . . 0.0 110.544 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 pttt 38.76 42.69 0.64 Allowed 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 113.707 -1.588 . . . . 0.0 114.447 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.5 141.33 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 45.1 t -111.82 85.34 2.12 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.411 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.515 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 21.0 m-30 -119.89 168.56 10.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 124.618 1.198 . . . . 0.0 109.286 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.84 41.41 1.08 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 t30 55.36 42.62 29.98 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 113.648 -1.615 . . . . 0.0 112.037 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.65 -27.13 0.27 Allowed Glycine 0 N--CA 1.49 2.298 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.994 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.8 tt -121.39 138.07 27.72 Favored Pre-proline 0 N--CA 1.496 1.825 0 CA-C-O 119.348 -0.358 . . . . 0.0 110.06 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.515 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 9.4 Cg_endo . . . . . 0 C--N 1.315 -1.193 0 C-N-CA 121.529 1.486 . . . . 0.0 110.765 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -144.01 -89.91 0.11 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 107.981 -2.048 . . . . 0.0 107.981 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 175.07 -167.56 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 124.788 0.934 . . . . 0.0 111.047 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 m -39.4 145.2 0.12 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -126.43 33.05 5.07 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 111.949 -2.387 . . . . 0.0 109.461 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.7 t -81.06 -69.65 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.625 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 45.9 t-105 -56.33 -41.93 76.86 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.958 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.1 tt -150.79 116.13 3.28 Favored Pre-proline 0 N--CA 1.485 1.322 0 CA-C-N 113.824 -1.535 . . . . 0.0 108.373 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -65.47 144.64 80.26 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.98 1.786 . . . . 0.0 110.738 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 p -63.38 152.97 36.6 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 124.245 0.966 . . . . 0.0 110.179 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.0 mm -110.18 -51.92 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 124.318 1.011 . . . . 0.0 109.767 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.6 m -70.02 -58.11 4.21 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.931 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.95 -11.31 27.3 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.575 -1.193 . . . . 0.0 112.089 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.18 -47.24 81.72 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 123.451 0.469 . . . . 0.0 110.874 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.75 -67.59 0.46 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.292 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.61 -70.62 0.92 Allowed Glycine 0 N--CA 1.494 2.547 0 O-C-N 124.233 0.958 . . . . 0.0 110.758 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -77.82 -173.67 3.17 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.687 -0.757 . . . . 0.0 109.049 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.0 m -149.21 129.36 13.61 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 123.372 0.42 . . . . 0.0 110.335 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 40.9 t -74.11 124.75 26.89 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.093 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.4 tttt -155.39 137.18 14.39 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.399 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 50.48 61.85 2.99 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 124.277 0.986 . . . . 0.0 110.888 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 pttt 38.37 44.86 0.76 Allowed 'General case' 0 N--CA 1.502 2.164 0 CA-C-N 114.051 -1.432 . . . . 0.0 114.448 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.52 136.38 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 114.207 -1.36 . . . . 0.0 107.656 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 53.8 t -104.38 65.88 0.79 Allowed 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.009 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.483 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 16.9 m-30 -106.12 166.25 10.64 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.184 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.7 ptt85 -89.64 34.49 0.83 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 25' ' ' TYR . 11.1 m120 50.65 51.14 17.51 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 113.587 -1.642 . . . . 0.0 110.541 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.25 -29.71 0.09 OUTLIER Glycine 0 N--CA 1.489 2.188 0 CA-C-N 114.347 -1.297 . . . . 0.0 113.274 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.09 146.9 20.91 Favored Pre-proline 0 N--CA 1.497 1.915 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.483 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 9.4 Cg_endo . . . . . 0 N--CA 1.488 1.163 0 C-N-CA 122.157 1.904 . . . . 0.0 111.476 -177.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.13 -90.02 0.09 OUTLIER Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.29 -167.34 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 O-C-N 125.02 1.071 . . . . 0.0 111.301 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 p -41.35 146.51 0.2 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.588 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 0.6 OUTLIER -125.41 29.54 6.01 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 111.29 -2.687 . . . . 0.0 109.989 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.78 -65.75 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-N 113.798 -1.547 . . . . 0.0 108.548 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -81.4 -41.56 21.73 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.265 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.3 pt -127.01 89.61 51.58 Favored Pre-proline 0 N--CA 1.486 1.353 0 O-C-N 124.664 1.227 . . . . 0.0 110.575 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -58.11 142.69 97.15 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.732 2.288 . . . . 0.0 112.444 173.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -68.87 163.76 23.57 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.227 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.3 mm -131.8 -58.96 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 t -69.36 -52.98 21.9 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.261 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.56 72.76 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.025 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.29 -28.18 40.27 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 123.584 0.553 . . . . 0.0 111.794 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.0 mt -72.49 -76.7 0.11 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.198 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.82 -60.55 7.92 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.69 179.87 5.77 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.174 -1.013 . . . . 0.0 108.63 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.4 m -146.7 131.3 17.81 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 123.475 0.484 . . . . 0.0 110.193 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 12.9 t -73.34 125.73 28.51 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.32 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.51 141.25 8.93 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 114.276 -1.329 . . . . 0.0 107.806 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.0 m120 53.91 54.47 9.72 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 124.301 1.001 . . . . 0.0 109.127 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt 38.67 45.2 0.87 Allowed 'General case' 0 N--CA 1.502 2.161 0 CA-C-N 113.618 -1.628 . . . . 0.0 113.984 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.424 HG11 ' CG ' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -150.72 139.51 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-N 114.39 -1.277 . . . . 0.0 107.899 179.683 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.588 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 61.7 m -99.68 59.92 1.1 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.472 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 10.9 m-30 -101.16 166.22 10.9 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.923 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.03 52.06 1.28 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.6 t30 51.49 37.77 20.33 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 113.564 -1.653 . . . . 0.0 112.937 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 164.03 -34.77 0.29 Allowed Glycine 0 N--CA 1.491 2.332 0 C-N-CA 120.134 -1.031 . . . . 0.0 114.502 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.3 tt -105.98 138.35 19.63 Favored Pre-proline 0 N--CA 1.498 1.959 0 CA-C-O 119.333 -0.365 . . . . 0.0 110.625 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.472 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 3.3 Cg_endo . . . . . 0 C--N 1.316 -1.141 0 C-N-CA 121.472 1.448 . . . . 0.0 109.371 170.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -147.15 -89.01 0.08 OUTLIER Glycine 0 N--CA 1.483 1.779 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 176.04 -171.43 0.07 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 124.92 1.012 . . . . 0.0 112.215 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.401 ' H ' ' HG ' ' A' ' 4' ' ' SER . 6.5 m -45.71 147.24 0.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.7 m -108.78 25.89 11.21 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 111.003 -2.817 . . . . 0.0 110.832 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.8 t -83.48 -66.56 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 113.999 -1.455 . . . . 0.0 109.15 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 30.3 t-105 -59.34 -41.82 90.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 124.356 1.035 . . . . 0.0 109.975 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.4 tt -162.54 124.25 1.61 Allowed Pre-proline 0 N--CA 1.485 1.311 0 CA-C-N 113.562 -1.654 . . . . 0.0 108.417 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -67.71 148.33 77.43 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.24 1.96 . . . . 0.0 110.092 171.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.408 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 1.7 p -67.85 173.77 4.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 124.064 0.852 . . . . 0.0 111.67 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.09 -58.36 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.0 p -66.09 -56.98 8.77 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.998 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.2 -32.31 73.67 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.491 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.59 -26.65 33.75 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 123.499 0.499 . . . . 0.0 112.037 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.0 mt -70.24 -75.4 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 123.824 0.703 . . . . 0.0 109.885 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.58 -57.82 14.85 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -76.9 -171.93 2.13 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 114.068 -1.066 . . . . 0.0 109.455 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.5 t -146.57 153.43 40.35 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.427 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.408 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 1.2 m -103.05 104.5 14.68 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.94 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -137.25 140.38 41.6 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.369 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 47.58 63.88 1.82 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 124.485 1.115 . . . . 0.0 110.806 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 38.27 45.94 0.84 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 114.178 -1.374 . . . . 0.0 114.139 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.97 132.53 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.598 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 37.3 t -100.86 68.44 1.29 Allowed 'General case' 0 N--CA 1.506 2.375 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.462 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 14.9 m-30 -111.19 160.24 17.13 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.915 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -103.15 69.53 1.02 Allowed 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 64.76 77.49 0.31 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 113.295 -1.775 . . . . 0.0 111.434 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.86 -18.4 1.91 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 116.732 1.453 . . . . 0.0 116.732 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.8 tp -89.83 128.15 51.32 Favored Pre-proline 0 N--CA 1.499 2.009 0 CA-C-N 118.349 1.075 . . . . 0.0 109.893 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.462 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 10.1 Cg_endo . . . . . 0 N--CA 1.488 1.155 0 C-N-CA 122.032 1.821 . . . . 0.0 111.396 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.58 -88.05 0.08 OUTLIER Glycine 0 N--CA 1.485 1.946 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 174.91 -171.77 0.06 Allowed 'General case' 0 N--CA 1.503 2.202 0 O-C-N 124.867 0.98 . . . . 0.0 112.147 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.458 ' H ' ' HG ' ' A' ' 4' ' ' SER . 4.1 m -49.63 147.85 3.29 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.552 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 0.8 OUTLIER -127.54 36.49 4.37 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 112.077 -2.329 . . . . 0.0 110.484 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.0 t -66.69 -59.69 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.4 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 46.5 t-105 -67.79 -51.15 52.18 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.936 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -132.35 152.97 81.01 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 124.546 1.154 . . . . 0.0 110.546 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -74.41 167.95 25.94 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.854 2.369 . . . . 0.0 110.877 172.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -86.77 177.74 7.22 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.327 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.95 -74.77 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.5 m -63.6 -42.11 98.28 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.16 11.31 4.31 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.857 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.93 -51.07 5.24 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.3 -66.3 0.64 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.488 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.93 -75.39 0.31 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.05 -172.49 1.67 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.3 m -148.92 139.46 22.58 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.623 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.414 ' HB2' ' SG ' ' A' ' 10' ' ' CYS . 10.2 t -81.27 114.62 20.19 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.178 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -147.05 135.71 22.04 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.131 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.9 t30 48.98 68.16 0.76 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 124.525 1.14 . . . . 0.0 110.665 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? 38.33 42.25 0.51 Allowed 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.41 HG11 ' CG ' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -151.02 135.14 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.633 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.552 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 50.7 m -99.88 56.12 0.96 Allowed 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.444 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 10.4 m-30 -99.49 167.88 10.33 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.384 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -94.13 40.72 1.08 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 56.18 39.84 30.21 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.936 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.79 -34.26 0.19 Allowed Glycine 0 N--CA 1.488 2.143 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.875 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.8 tt -113.35 138.17 22.35 Favored Pre-proline 0 N--CA 1.498 1.972 0 CA-C-O 119.256 -0.402 . . . . 0.0 110.827 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.444 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 4.4 Cg_endo . . . . . 0 C--N 1.317 -1.113 0 C-N-CA 121.614 1.543 . . . . 0.0 109.353 171.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.98 -90.48 0.08 OUTLIER Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 172.02 -165.38 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 125.203 1.179 . . . . 0.0 110.248 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.1 m -41.61 146.43 0.23 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.85 34.79 1.58 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 111.647 -2.524 . . . . 0.0 108.218 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.5 t -70.16 -60.84 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.599 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -64.57 -49.88 69.45 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.297 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 pp -132.39 161.82 60.79 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 124.643 1.214 . . . . 0.0 110.722 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -66.34 152.54 80.77 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.32 2.013 . . . . 0.0 109.841 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.04 166.14 18.72 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 123.921 0.763 . . . . 0.0 112.207 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.0 mm -89.88 -36.91 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.88 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.413 ' C ' ' H ' ' A' ' 14' ' ' ALA . 32.6 t -80.13 -110.78 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.585 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 60.14 -2.18 0.16 Allowed 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.413 ' H ' ' C ' ' A' ' 12' ' ' SER . . . -75.64 -32.62 60.3 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 123.486 0.491 . . . . 0.0 111.603 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.3 mp -56.48 -36.75 69.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 124.161 0.913 . . . . 0.0 110.838 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.29 1.16 0.68 Allowed Glycine 0 N--CA 1.487 2.083 0 CA-C-N 114.205 -1.362 . . . . 0.0 109.939 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.29 150.49 43.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 123.933 0.431 . . . . 0.0 111.863 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.7 m -133.3 131.01 39.68 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.264 -1.335 . . . . 0.0 107.824 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.2 t -71.32 121.63 18.84 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.608 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.472 ' HZ3' ' H ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -157.63 145.71 18.98 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 113.859 -1.519 . . . . 0.0 108.466 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.0 m120 52.38 56.4 7.75 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 124.22 0.95 . . . . 0.0 109.857 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 pttt 38.44 39.5 0.3 Allowed 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 113.538 -1.665 . . . . 0.0 114.825 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -150.3 143.98 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 36.4 t -102.68 67.22 0.98 Allowed 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.77 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.462 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 14.7 m-30 -109.56 169.4 8.73 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.797 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 -98.97 39.24 1.29 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.472 ' H ' ' HZ3' ' A' ' 20' ' ' LYS . 1.8 t30 55.9 44.05 26.44 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 113.398 -1.728 . . . . 0.0 110.519 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 165.41 -32.31 0.23 Allowed Glycine 0 N--CA 1.489 2.209 0 CA-C-N 114.843 -1.071 . . . . 0.0 113.481 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.1 tt -112.76 136.16 21.6 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 123.899 0.411 . . . . 0.0 110.058 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.462 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 9.8 Cg_endo . . . . . 0 C--N 1.314 -1.248 0 C-N-CA 121.625 1.55 . . . . 0.0 108.575 170.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.42 -88.55 0.07 OUTLIER Glycine 0 N--CA 1.483 1.821 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 174.79 -166.34 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.91 1.006 . . . . 0.0 110.892 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.9 m -42.57 146.52 0.34 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -135.11 44.78 2.57 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 111.266 -2.697 . . . . 0.0 108.113 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.8 t -80.55 -66.28 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 114.222 -1.354 . . . . 0.0 109.428 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 28.0 t-105 -67.04 -45.47 77.35 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.353 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.73 165.57 14.91 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 124.446 1.092 . . . . 0.0 109.607 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -74.86 -172.22 1.18 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.557 2.171 . . . . 0.0 109.802 165.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 37.4 m -76.22 -167.54 0.78 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.468 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.54 -57.58 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.449 ' C ' ' H ' ' A' ' 14' ' ' ALA . 68.9 m -59.27 -83.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.894 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 67.91 -15.12 0.21 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 123.879 0.737 . . . . 0.0 112.76 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' A' ' 12' ' ' SER . . . -67.81 -34.78 77.41 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mt -67.37 -5.4 14.34 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.586 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.1 23.82 53.94 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.39 160.53 32.19 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.332 0.586 . . . . 0.0 112.007 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.1 m -145.16 132.74 20.88 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.351 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.4 t -70.8 111.36 6.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 123.87 0.731 . . . . 0.0 110.564 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -138.54 130.56 28.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.365 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 t30 53.77 66.18 1.3 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 124.384 1.052 . . . . 0.0 111.355 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt 36.27 38.88 0.07 Allowed 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 114.057 -1.429 . . . . 0.0 114.71 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 t -150.4 136.04 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 49.3 t -103.98 80.95 1.8 Allowed 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.023 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.481 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 13.2 m-30 -114.45 169.76 8.81 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.159 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -95.03 42.11 1.09 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 55.86 41.51 29.98 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 113.913 -1.494 . . . . 0.0 111.51 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 162.27 -35.27 0.35 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.23 -0.986 . . . . 0.0 113.886 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.7 tt -110.12 138.95 20.95 Favored Pre-proline 0 N--CA 1.498 1.972 0 CA-C-O 119.227 -0.415 . . . . 0.0 110.094 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.481 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 7.7 Cg_endo . . . . . 0 C--N 1.314 -1.246 0 C-N-CA 121.408 1.405 . . . . 0.0 109.826 172.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.09 -87.25 0.06 OUTLIER Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 177.34 -165.78 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.551 0.795 . . . . 0.0 113.076 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.4 p -35.29 143.89 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 119.07 2.989 . . . . 0.0 119.07 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.8 m -110.82 19.3 18.71 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 110.831 -2.895 . . . . 0.0 110.166 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.0 t -79.3 -69.3 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-N 113.607 -1.633 . . . . 0.0 109.101 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -61.7 -38.33 87.44 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.964 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 tt -160.91 114.18 1.32 Allowed Pre-proline 0 N--CA 1.486 1.375 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.204 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.22 142.23 98.92 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.509 2.139 . . . . 0.0 110.229 166.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 p -66.12 176.55 1.68 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 114.805 -1.089 . . . . 0.0 112.594 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.73 -59.19 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.0 m -70.36 -53.24 17.42 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.338 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.08 -20.1 64.92 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.386 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.22 -27.77 68.23 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 123.804 0.69 . . . . 0.0 109.951 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mt -73.63 -56.18 5.34 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.78 -73.06 0.68 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.5 m -83.63 -176.79 6.46 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.535 -0.832 . . . . 0.0 109.892 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.6 m -128.67 168.88 15.15 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.719 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.0 m -104.53 99.98 9.66 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.15 140.66 47.72 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.399 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 48.64 58.32 5.38 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 124.179 0.924 . . . . 0.0 110.616 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.9 pttm 38.82 47.64 1.23 Allowed 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 114.031 -1.44 . . . . 0.0 113.665 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.455 HG11 ' CG ' ' A' ' 25' ' ' TYR . 0.4 OUTLIER -150.9 137.17 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 114.018 -1.446 . . . . 0.0 107.178 179.598 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 39.8 t -92.15 54.89 2.46 Favored 'General case' 0 N--CA 1.507 2.385 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.906 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.546 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 9.3 m-30 -108.91 161.76 14.83 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.328 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 -89.65 41.7 1.05 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 55.39 37.16 28.49 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.978 -1.465 . . . . 0.0 110.86 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 171.68 -27.46 0.1 Allowed Glycine 0 N--CA 1.488 2.107 0 CA-C-N 114.754 -1.112 . . . . 0.0 114.038 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.7 tt -120.44 129.15 25.46 Favored Pre-proline 0 N--CA 1.498 1.953 0 CA-C-N 117.375 0.588 . . . . 0.0 111.433 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.546 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 16.9 Cg_endo . . . . . 0 C--N 1.316 -1.138 0 C-N-CA 122.354 2.036 . . . . 0.0 112.07 177.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -141.43 -89.64 0.15 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 175.64 -163.56 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 124.709 0.888 . . . . 0.0 112.385 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -49.49 129.87 19.52 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-N 114.575 -1.193 . . . . 0.0 114.203 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.527 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 0.8 OUTLIER -102.13 34.45 2.71 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 112.896 -1.956 . . . . 0.0 109.146 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.9 t -75.7 -67.29 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.171 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -67.91 -41.25 82.96 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.033 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.1 tp -147.62 125.86 6.04 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 124.504 1.128 . . . . 0.0 109.789 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -72.01 150.13 54.06 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.472 2.114 . . . . 0.0 111.432 177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -72.78 154.17 40.78 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.566 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.8 mt -117.59 -48.91 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.5 m -62.19 -41.93 98.8 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.785 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.93 -24.5 38.35 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.338 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.19 -44.78 53.15 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 123.984 0.802 . . . . 0.0 110.453 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.7 mt -91.8 45.61 1.23 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 124.416 1.073 . . . . 0.0 108.356 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.36 -98.19 0.11 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.0 m -82.75 -164.11 0.81 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.15 0.5 . . . . 0.0 112.167 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.5 t -146.65 158.54 43.92 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.922 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 t -97.39 120.79 38.4 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.506 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -155.2 135.31 13.04 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.289 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.66 68.52 0.72 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.568 1.168 . . . . 0.0 110.681 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.3 pttm 37.09 44.04 0.37 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 113.897 -1.501 . . . . 0.0 114.919 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -151.27 131.69 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.934 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 5.5 m -95.46 42.85 1.09 Allowed 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.98 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.56 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 3.2 m-30 -104.62 162.59 13.14 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.52 33.99 0.9 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 113.618 -1.628 . . . . 0.0 108.298 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 52.63 43.91 30.69 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.188 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 176.59 -22.16 0.05 OUTLIER Glycine 0 N--CA 1.488 2.116 0 CA-C-N 114.714 -1.13 . . . . 0.0 113.978 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -145.01 129.58 9.0 Favored Pre-proline 0 N--CA 1.5 2.051 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.56 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 15.2 Cg_endo . . . . . 0 N--CA 1.485 1.021 0 C-N-CA 122.214 1.942 . . . . 0.0 113.004 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 26' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.52 -91.51 0.11 Allowed Glycine 0 N--CA 1.482 1.716 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 170.96 -167.66 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 124.828 0.957 . . . . 0.0 111.995 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.2 p -36.96 146.48 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.435 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -133.59 31.06 3.74 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 112.486 -2.143 . . . . 0.0 111.035 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.3 t -73.07 -49.72 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-N 114.27 -1.332 . . . . 0.0 108.891 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -71.73 -50.24 31.91 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.774 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 pt -144.13 132.01 10.76 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 124.385 1.053 . . . . 0.0 109.627 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -69.51 152.9 70.66 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.389 2.059 . . . . 0.0 111.873 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.49 148.22 51.8 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.334 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.5 mm -112.87 -56.49 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 124.302 1.001 . . . . 0.0 108.559 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 t -65.88 -42.59 90.11 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.068 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.97 -16.29 57.13 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 113.795 -1.548 . . . . 0.0 112.144 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.64 -45.78 14.18 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -83.84 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.599 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -53.37 -66.39 2.76 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -72.45 175.21 6.44 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 114.697 -0.752 . . . . 0.0 110.59 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.4 m -148.96 142.21 25.07 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.726 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 30.1 t -79.36 85.14 5.2 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.725 0.774 . . . . 0.0 109.899 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt -104.79 145.32 30.54 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.322 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.9 p30 39.78 56.03 2.42 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 124.61 1.194 . . . . 0.0 111.206 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt 41.18 44.11 2.11 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 113.234 -1.803 . . . . 0.0 113.627 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.1 t -150.21 134.09 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.435 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 51.5 m -92.04 73.47 5.55 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.826 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.454 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 11.9 m-30 -112.54 167.18 10.66 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 124.241 0.963 . . . . 0.0 109.867 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.4 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -117.15 89.51 3.13 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 62.29 51.57 3.39 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.11 -1.405 . . . . 0.0 110.118 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.64 -2.86 71.22 Favored Glycine 0 N--CA 1.492 2.373 0 CA-C-N 114.042 -1.436 . . . . 0.0 115.781 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.74 130.28 43.61 Favored Pre-proline 0 N--CA 1.501 2.102 0 CA-C-N 118.131 0.966 . . . . 0.0 108.485 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.454 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 4.5 Cg_endo . . . . . 0 N--CA 1.487 1.139 0 C-N-CA 121.637 1.558 . . . . 0.0 112.09 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.29 -85.81 0.06 OUTLIER Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 177.75 -168.82 0.07 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 124.706 0.886 . . . . 0.0 111.11 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.8 m -45.92 147.32 1.01 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -131.18 33.56 4.12 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 112.207 -2.27 . . . . 0.0 109.306 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.29 -58.34 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.263 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -67.09 -54.78 18.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.265 0.978 . . . . 0.0 110.736 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.73 147.62 42.91 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 124.525 1.14 . . . . 0.0 110.406 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -72.51 156.71 53.82 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.924 2.416 . . . . 0.0 111.346 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 p -75.06 146.58 41.39 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.311 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.9 mt -94.28 -49.12 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 124.284 0.99 . . . . 0.0 110.213 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.4 m -66.03 -56.29 12.33 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.31 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.46 -4.49 15.08 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.483 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.25 -48.55 79.45 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.131 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.9 mt -82.58 74.94 9.51 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.17 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.64 -66.47 0.37 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.211 -1.955 . . . . 0.0 108.211 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.5 162.16 19.05 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 114.164 -1.018 . . . . 0.0 110.08 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.8 m -136.78 132.85 35.31 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.412 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 53.9 t -69.65 131.25 44.32 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.281 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -159.45 127.75 5.03 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.11 -1.405 . . . . 0.0 107.912 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 50.47 76.34 0.15 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.345 1.028 . . . . 0.0 112.614 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt 35.6 40.58 0.08 Allowed 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.4 HG11 ' CG ' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -150.77 135.86 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.2 56.55 0.64 Allowed 'General case' 0 N--CA 1.507 2.425 0 CA-C-O 122.459 1.123 . . . . 0.0 108.407 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.441 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 10.8 m-30 -95.63 172.05 8.29 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 112.739 -2.028 . . . . 0.0 111.791 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -93.46 39.55 1.06 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 55.48 39.83 31.15 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 113.797 -1.547 . . . . 0.0 111.486 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 169.43 -34.88 0.18 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 120.248 -0.977 . . . . 0.0 114.037 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.9 tt -117.62 137.61 24.39 Favored Pre-proline 0 N--CA 1.497 1.909 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.562 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.441 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 7.8 Cg_endo . . . . . 0 N--CA 1.487 1.132 0 C-N-CA 121.728 1.619 . . . . 0.0 110.384 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.02 -84.6 0.05 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 175.73 -167.72 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 O-C-N 124.682 0.872 . . . . 0.0 110.727 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 p -44.59 141.89 1.85 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.22 34.76 4.83 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 112.039 -2.346 . . . . 0.0 109.105 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.9 t -79.73 -68.35 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.347 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 41.6 t-105 -60.22 -43.74 95.77 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.894 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.0 tp -153.61 122.22 3.12 Favored Pre-proline 0 N--CA 1.487 1.398 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.099 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -71.12 146.31 51.56 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.365 2.043 . . . . 0.0 111.313 174.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.2 p -69.13 149.11 49.02 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.09 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.1 mm -104.75 -43.79 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 124.469 1.106 . . . . 0.0 109.147 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.8 m -70.42 -57.57 4.67 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.014 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.11 -24.36 67.86 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.851 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.71 -27.87 30.64 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 123.484 0.49 . . . . 0.0 111.327 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 34.2 mt -67.53 -80.37 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 124.187 0.929 . . . . 0.0 110.02 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.4 -56.39 17.84 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.4 168.26 20.38 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.266 -0.967 . . . . 0.0 110.164 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.8 m -144.36 125.1 14.16 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.113 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 38.0 t -62.36 129.34 40.24 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.776 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.65 125.42 6.47 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.185 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 50.5 t30 49.08 73.88 0.21 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.58 1.175 . . . . 0.0 111.801 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt 36.01 47.49 0.44 Allowed 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.401 HG11 ' CG ' ' A' ' 25' ' ' TYR . 0.6 OUTLIER -150.99 130.9 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.39 45.8 0.95 Allowed 'General case' 0 N--CA 1.51 2.569 0 CA-C-O 122.44 1.114 . . . . 0.0 109.751 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.412 ' C ' ' H ' ' A' ' 27' ' ' ASN . 11.3 m-30 -90.2 169.63 10.98 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.06 -1.882 . . . . 0.0 110.859 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -90.71 36.85 0.9 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 25' ' ' TYR . 9.7 m120 52.13 40.79 29.41 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.042 -1.435 . . . . 0.0 110.345 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.35 -26.76 0.09 OUTLIER Glycine 0 N--CA 1.486 2.021 0 CA-C-N 114.387 -1.279 . . . . 0.0 113.483 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.1 tt -128.01 133.25 24.92 Favored Pre-proline 0 N--CA 1.497 1.884 0 CA-C-N 117.204 0.502 . . . . 0.0 110.249 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.4 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 9.7 Cg_endo . . . . . 0 N--CA 1.489 1.213 0 C-N-CA 121.847 1.698 . . . . 0.0 109.876 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.54 -91.1 0.09 OUTLIER Glycine 0 N--CA 1.482 1.74 0 N-CA-C 106.936 -2.466 . . . . 0.0 106.936 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 171.8 -159.35 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 125.167 1.157 . . . . 0.0 110.318 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.9 p -35.66 141.72 0.08 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.66 31.08 3.71 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 111.749 -2.478 . . . . 0.0 108.725 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.3 t -72.05 -63.64 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-N 113.752 -1.567 . . . . 0.0 110.483 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.9 t-105 -66.66 -47.63 71.9 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.998 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.06 162.96 53.61 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 124.479 1.112 . . . . 0.0 110.85 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -67.18 164.89 28.54 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.559 2.173 . . . . 0.0 111.056 172.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.73 171.27 14.65 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.215 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -95.93 -43.13 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.161 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 14' ' ' ALA . 39.7 t -73.84 -104.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.376 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 64.94 -9.47 0.19 Allowed 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.415 ' H ' ' C ' ' A' ' 12' ' ' SER . . . -66.79 -41.73 87.15 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 123.433 0.458 . . . . 0.0 109.922 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.1 mt -62.07 -33.2 73.96 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.167 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 128.08 27.13 0.95 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.6 m -65.15 109.79 2.31 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.336 0.588 . . . . 0.0 110.336 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.2 m -89.77 128.64 36.17 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 114.284 -1.325 . . . . 0.0 109.221 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 39.8 t -80.67 102.28 9.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 124.138 0.899 . . . . 0.0 110.599 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -138.06 145.98 42.41 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.889 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 50.23 57.53 6.48 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.461 1.1 . . . . 0.0 110.544 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 pttt 38.76 42.69 0.64 Allowed 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 113.707 -1.588 . . . . 0.0 114.447 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.5 141.33 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 45.1 t -111.82 85.34 2.12 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.411 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.515 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 21.0 m-30 -119.89 168.56 10.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 124.618 1.198 . . . . 0.0 109.286 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.84 41.41 1.08 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 t30 55.36 42.62 29.98 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 113.648 -1.615 . . . . 0.0 112.037 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.65 -27.13 0.27 Allowed Glycine 0 N--CA 1.49 2.298 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.994 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.8 tt -121.39 138.07 27.72 Favored Pre-proline 0 N--CA 1.496 1.825 0 CA-C-O 119.348 -0.358 . . . . 0.0 110.06 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.515 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 9.4 Cg_endo . . . . . 0 C--N 1.315 -1.193 0 C-N-CA 121.529 1.486 . . . . 0.0 110.765 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -144.01 -89.91 0.11 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 107.981 -2.048 . . . . 0.0 107.981 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 175.07 -167.56 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 124.788 0.934 . . . . 0.0 111.047 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 m -39.4 145.2 0.12 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -126.43 33.05 5.07 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 111.949 -2.387 . . . . 0.0 109.461 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.7 t -81.06 -69.65 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.625 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 45.9 t-105 -56.33 -41.93 76.86 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.958 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.1 tt -150.79 116.13 3.28 Favored Pre-proline 0 N--CA 1.485 1.322 0 CA-C-N 113.824 -1.535 . . . . 0.0 108.373 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -65.47 144.64 80.26 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.98 1.786 . . . . 0.0 110.738 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 p -63.38 152.97 36.6 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 124.245 0.966 . . . . 0.0 110.179 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.0 mm -110.18 -51.92 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 124.318 1.011 . . . . 0.0 109.767 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.6 m -70.02 -58.11 4.21 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.931 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.95 -11.31 27.3 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.575 -1.193 . . . . 0.0 112.089 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.18 -47.24 81.72 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 123.451 0.469 . . . . 0.0 110.874 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.75 -67.59 0.46 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.292 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.61 -70.62 0.92 Allowed Glycine 0 N--CA 1.494 2.547 0 O-C-N 124.233 0.958 . . . . 0.0 110.758 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -77.82 -173.67 3.17 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.687 -0.757 . . . . 0.0 109.049 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.0 m -149.21 129.36 13.61 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 123.372 0.42 . . . . 0.0 110.335 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 40.9 t -74.11 124.75 26.89 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.093 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.4 tttt -155.39 137.18 14.39 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.399 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 50.48 61.85 2.99 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 124.277 0.986 . . . . 0.0 110.888 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 pttt 38.37 44.86 0.76 Allowed 'General case' 0 N--CA 1.502 2.164 0 CA-C-N 114.051 -1.432 . . . . 0.0 114.448 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.52 136.38 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 114.207 -1.36 . . . . 0.0 107.656 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 53.8 t -104.38 65.88 0.79 Allowed 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.009 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.483 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 16.9 m-30 -106.12 166.25 10.64 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.184 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.7 ptt85 -89.64 34.49 0.83 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 25' ' ' TYR . 11.1 m120 50.65 51.14 17.51 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 113.587 -1.642 . . . . 0.0 110.541 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.25 -29.71 0.09 OUTLIER Glycine 0 N--CA 1.489 2.188 0 CA-C-N 114.347 -1.297 . . . . 0.0 113.274 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.09 146.9 20.91 Favored Pre-proline 0 N--CA 1.497 1.915 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.483 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 9.4 Cg_endo . . . . . 0 N--CA 1.488 1.163 0 C-N-CA 122.157 1.904 . . . . 0.0 111.476 -177.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.13 -90.02 0.09 OUTLIER Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.29 -167.34 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 O-C-N 125.02 1.071 . . . . 0.0 111.301 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 p -41.35 146.51 0.2 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.588 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 0.6 OUTLIER -125.41 29.54 6.01 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 111.29 -2.687 . . . . 0.0 109.989 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.78 -65.75 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-N 113.798 -1.547 . . . . 0.0 108.548 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -81.4 -41.56 21.73 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.265 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.3 pt -127.01 89.61 51.58 Favored Pre-proline 0 N--CA 1.486 1.353 0 O-C-N 124.664 1.227 . . . . 0.0 110.575 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -58.11 142.69 97.15 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.732 2.288 . . . . 0.0 112.444 173.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -68.87 163.76 23.57 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.227 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.3 mm -131.8 -58.96 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 t -69.36 -52.98 21.9 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.261 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.56 72.76 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.025 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.29 -28.18 40.27 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 123.584 0.553 . . . . 0.0 111.794 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.0 mt -72.49 -76.7 0.11 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.198 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.82 -60.55 7.92 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.69 179.87 5.77 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.174 -1.013 . . . . 0.0 108.63 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.4 m -146.7 131.3 17.81 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 123.475 0.484 . . . . 0.0 110.193 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 12.9 t -73.34 125.73 28.51 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.32 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.51 141.25 8.93 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 114.276 -1.329 . . . . 0.0 107.806 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.0 m120 53.91 54.47 9.72 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 124.301 1.001 . . . . 0.0 109.127 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt 38.67 45.2 0.87 Allowed 'General case' 0 N--CA 1.502 2.161 0 CA-C-N 113.618 -1.628 . . . . 0.0 113.984 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.424 HG11 ' CG ' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -150.72 139.51 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-N 114.39 -1.277 . . . . 0.0 107.899 179.683 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.588 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 61.7 m -99.68 59.92 1.1 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.472 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 10.9 m-30 -101.16 166.22 10.9 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.923 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.03 52.06 1.28 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.6 t30 51.49 37.77 20.33 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 113.564 -1.653 . . . . 0.0 112.937 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 164.03 -34.77 0.29 Allowed Glycine 0 N--CA 1.491 2.332 0 C-N-CA 120.134 -1.031 . . . . 0.0 114.502 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.3 tt -105.98 138.35 19.63 Favored Pre-proline 0 N--CA 1.498 1.959 0 CA-C-O 119.333 -0.365 . . . . 0.0 110.625 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.472 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 3.3 Cg_endo . . . . . 0 C--N 1.316 -1.141 0 C-N-CA 121.472 1.448 . . . . 0.0 109.371 170.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -147.15 -89.01 0.08 OUTLIER Glycine 0 N--CA 1.483 1.779 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 176.04 -171.43 0.07 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 124.92 1.012 . . . . 0.0 112.215 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.401 ' H ' ' HG ' ' A' ' 4' ' ' SER . 6.5 m -45.71 147.24 0.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.7 m -108.78 25.89 11.21 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 111.003 -2.817 . . . . 0.0 110.832 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.8 t -83.48 -66.56 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 113.999 -1.455 . . . . 0.0 109.15 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 30.3 t-105 -59.34 -41.82 90.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 124.356 1.035 . . . . 0.0 109.975 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.4 tt -162.54 124.25 1.61 Allowed Pre-proline 0 N--CA 1.485 1.311 0 CA-C-N 113.562 -1.654 . . . . 0.0 108.417 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -67.71 148.33 77.43 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.24 1.96 . . . . 0.0 110.092 171.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.408 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 1.7 p -67.85 173.77 4.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 124.064 0.852 . . . . 0.0 111.67 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.09 -58.36 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.0 p -66.09 -56.98 8.77 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.998 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.2 -32.31 73.67 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.491 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.59 -26.65 33.75 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 123.499 0.499 . . . . 0.0 112.037 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.0 mt -70.24 -75.4 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 123.824 0.703 . . . . 0.0 109.885 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.58 -57.82 14.85 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -76.9 -171.93 2.13 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 114.068 -1.066 . . . . 0.0 109.455 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.5 t -146.57 153.43 40.35 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.427 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.408 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 1.2 m -103.05 104.5 14.68 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.94 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -137.25 140.38 41.6 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.369 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 47.58 63.88 1.82 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 124.485 1.115 . . . . 0.0 110.806 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 38.27 45.94 0.84 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 114.178 -1.374 . . . . 0.0 114.139 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.97 132.53 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.598 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 37.3 t -100.86 68.44 1.29 Allowed 'General case' 0 N--CA 1.506 2.375 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.462 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 14.9 m-30 -111.19 160.24 17.13 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.915 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -103.15 69.53 1.02 Allowed 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 64.76 77.49 0.31 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 113.295 -1.775 . . . . 0.0 111.434 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.86 -18.4 1.91 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 116.732 1.453 . . . . 0.0 116.732 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.8 tp -89.83 128.15 51.32 Favored Pre-proline 0 N--CA 1.499 2.009 0 CA-C-N 118.349 1.075 . . . . 0.0 109.893 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.462 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 10.1 Cg_endo . . . . . 0 N--CA 1.488 1.155 0 C-N-CA 122.032 1.821 . . . . 0.0 111.396 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 25' ' ' TYR . 1.2 m . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.58 -88.05 0.08 OUTLIER Glycine 0 N--CA 1.485 1.946 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 174.91 -171.77 0.06 Allowed 'General case' 0 N--CA 1.503 2.202 0 O-C-N 124.867 0.98 . . . . 0.0 112.147 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.1 m -49.63 147.85 3.29 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.564 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 0.8 OUTLIER -127.54 36.49 4.37 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 112.077 -2.329 . . . . 0.0 110.484 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.0 t -66.69 -59.69 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.4 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 46.5 t-105 -67.79 -51.15 52.18 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.936 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.4 HD12 ' O ' ' A' ' 8' ' ' ILE . 1.1 pp -132.35 152.97 81.01 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 124.546 1.154 . . . . 0.0 110.546 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -74.41 167.95 25.94 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.854 2.369 . . . . 0.0 110.877 172.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.427 ' SG ' ' HB2' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -86.77 177.74 7.22 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.327 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.95 -74.77 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.5 m -63.6 -42.11 98.28 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.16 11.31 4.31 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.857 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.93 -51.07 5.24 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.3 -66.3 0.64 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.488 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.93 -75.39 0.31 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.05 -172.49 1.67 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.3 m -148.92 139.46 22.58 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.623 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.427 ' HB2' ' SG ' ' A' ' 10' ' ' CYS . 10.2 t -81.27 114.62 20.19 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.178 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -147.05 135.71 22.04 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.131 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.9 t30 48.98 68.16 0.76 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 124.525 1.14 . . . . 0.0 110.665 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? 38.33 42.25 0.51 Allowed 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.522 HG13 ' CG ' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -151.02 135.14 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.633 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.564 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 50.7 m -99.88 56.12 0.96 Allowed 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.522 ' CG ' HG13 ' A' ' 23' ' ' VAL . 10.4 m-30 -99.49 167.88 10.33 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.384 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.45 ' HB3' HG22 ' A' ' 29' ' ' ILE . 2.0 ttt85 -94.13 40.72 1.08 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 56.18 39.84 30.21 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.936 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.79 -34.26 0.19 Allowed Glycine 0 N--CA 1.488 2.143 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.875 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.45 HG22 ' HB3' ' A' ' 26' ' ' ARG . 13.8 tt -113.35 138.17 22.35 Favored Pre-proline 0 N--CA 1.498 1.972 0 CA-C-O 119.256 -0.402 . . . . 0.0 110.827 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.477 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 4.4 Cg_endo . . . . . 0 C--N 1.317 -1.113 0 C-N-CA 121.614 1.543 . . . . 0.0 109.353 171.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.98 -90.48 0.08 OUTLIER Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 172.02 -165.38 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 125.203 1.179 . . . . 0.0 110.248 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.1 m -41.61 146.43 0.23 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.85 34.79 1.58 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 111.647 -2.524 . . . . 0.0 108.218 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.5 t -70.16 -60.84 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.599 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -64.57 -49.88 69.45 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.297 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 pp -132.39 161.82 60.79 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 124.643 1.214 . . . . 0.0 110.722 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -66.34 152.54 80.77 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.32 2.013 . . . . 0.0 109.841 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.04 166.14 18.72 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 123.921 0.763 . . . . 0.0 112.207 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.0 mm -89.88 -36.91 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.88 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.6 t -80.13 -110.78 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.585 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 60.14 -2.18 0.16 Allowed 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.64 -32.62 60.3 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 123.486 0.491 . . . . 0.0 111.603 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.471 ' H ' HD12 ' A' ' 15' ' ' LEU . 5.3 mp -56.48 -36.75 69.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 124.161 0.913 . . . . 0.0 110.838 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.29 1.16 0.68 Allowed Glycine 0 N--CA 1.487 2.083 0 CA-C-N 114.205 -1.362 . . . . 0.0 109.939 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.29 150.49 43.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 123.933 0.431 . . . . 0.0 111.863 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.7 m -133.3 131.01 39.68 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.264 -1.335 . . . . 0.0 107.824 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.2 t -71.32 121.63 18.84 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.608 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.616 ' HZ1' ' H ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -157.63 145.71 18.98 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 113.859 -1.519 . . . . 0.0 108.466 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.0 m120 52.38 56.4 7.75 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 124.22 0.95 . . . . 0.0 109.857 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 pttt 38.44 39.5 0.3 Allowed 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 113.538 -1.665 . . . . 0.0 114.825 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -150.3 143.98 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 36.4 t -102.68 67.22 0.98 Allowed 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.77 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.488 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 14.7 m-30 -109.56 169.4 8.73 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.797 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.438 ' HB3' HG22 ' A' ' 29' ' ' ILE . 25.0 ttp180 -98.97 39.24 1.29 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.616 ' H ' ' HZ1' ' A' ' 20' ' ' LYS . 1.8 t30 55.9 44.05 26.44 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 113.398 -1.728 . . . . 0.0 110.519 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 165.41 -32.31 0.23 Allowed Glycine 0 N--CA 1.489 2.209 0 CA-C-N 114.843 -1.071 . . . . 0.0 113.481 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.438 HG22 ' HB3' ' A' ' 26' ' ' ARG . 14.1 tt -112.76 136.16 21.6 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 123.899 0.411 . . . . 0.0 110.058 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.488 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 9.8 Cg_endo . . . . . 0 C--N 1.314 -1.248 0 C-N-CA 121.625 1.55 . . . . 0.0 108.575 170.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.42 -88.55 0.07 OUTLIER Glycine 0 N--CA 1.483 1.821 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 174.79 -166.34 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.91 1.006 . . . . 0.0 110.892 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.9 m -42.57 146.52 0.34 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -135.11 44.78 2.57 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 111.266 -2.697 . . . . 0.0 108.113 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.8 t -80.55 -66.28 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 114.222 -1.354 . . . . 0.0 109.428 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.446 ' HB3' HD13 ' A' ' 8' ' ' ILE . 28.0 t-105 -67.04 -45.47 77.35 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.353 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.595 HD13 ' H ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -116.73 165.57 14.91 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 124.446 1.092 . . . . 0.0 109.607 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -74.86 -172.22 1.18 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.557 2.171 . . . . 0.0 109.802 165.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 37.4 m -76.22 -167.54 0.78 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.468 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.54 -57.58 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.424 ' C ' ' H ' ' A' ' 14' ' ' ALA . 68.9 m -59.27 -83.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.894 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 67.91 -15.12 0.21 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 123.879 0.737 . . . . 0.0 112.76 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.424 ' H ' ' C ' ' A' ' 12' ' ' SER . . . -67.81 -34.78 77.41 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mt -67.37 -5.4 14.34 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.586 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.1 23.82 53.94 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.39 160.53 32.19 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.332 0.586 . . . . 0.0 112.007 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.1 m -145.16 132.74 20.88 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.351 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.4 t -70.8 111.36 6.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 123.87 0.731 . . . . 0.0 110.564 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -138.54 130.56 28.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.365 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 t30 53.77 66.18 1.3 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 124.384 1.052 . . . . 0.0 111.355 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt 36.27 38.88 0.07 Allowed 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 114.057 -1.429 . . . . 0.0 114.71 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.428 HG13 ' CE1' ' A' ' 25' ' ' TYR . 2.8 t -150.4 136.04 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 49.3 t -103.98 80.95 1.8 Allowed 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.023 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.512 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 13.2 m-30 -114.45 169.76 8.81 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.159 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.521 ' HB3' HG22 ' A' ' 29' ' ' ILE . 7.2 ttp180 -95.03 42.11 1.09 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 55.86 41.51 29.98 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 113.913 -1.494 . . . . 0.0 111.51 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 162.27 -35.27 0.35 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.23 -0.986 . . . . 0.0 113.886 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.521 HG22 ' HB3' ' A' ' 26' ' ' ARG . 13.7 tt -110.12 138.95 20.95 Favored Pre-proline 0 N--CA 1.498 1.972 0 CA-C-O 119.227 -0.415 . . . . 0.0 110.094 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.512 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 7.7 Cg_endo . . . . . 0 C--N 1.314 -1.246 0 C-N-CA 121.408 1.405 . . . . 0.0 109.826 172.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.09 -87.25 0.06 OUTLIER Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 177.34 -165.78 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.551 0.795 . . . . 0.0 113.076 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.4 p -35.29 143.89 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 119.07 2.989 . . . . 0.0 119.07 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.8 m -110.82 19.3 18.71 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 110.831 -2.895 . . . . 0.0 110.166 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.0 t -79.3 -69.3 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-N 113.607 -1.633 . . . . 0.0 109.101 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -61.7 -38.33 87.44 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.964 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 tt -160.91 114.18 1.32 Allowed Pre-proline 0 N--CA 1.486 1.375 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.204 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.22 142.23 98.92 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.509 2.139 . . . . 0.0 110.229 166.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 p -66.12 176.55 1.68 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 114.805 -1.089 . . . . 0.0 112.594 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.73 -59.19 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.0 m -70.36 -53.24 17.42 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.338 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.08 -20.1 64.92 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.386 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.22 -27.77 68.23 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 123.804 0.69 . . . . 0.0 109.951 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mt -73.63 -56.18 5.34 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.78 -73.06 0.68 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.5 m -83.63 -176.79 6.46 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.535 -0.832 . . . . 0.0 109.892 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.6 m -128.67 168.88 15.15 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.719 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.0 m -104.53 99.98 9.66 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.15 140.66 47.72 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.399 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 48.64 58.32 5.38 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 124.179 0.924 . . . . 0.0 110.616 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.9 pttm 38.82 47.64 1.23 Allowed 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 114.031 -1.44 . . . . 0.0 113.665 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.561 HG13 ' CG ' ' A' ' 25' ' ' TYR . 0.4 OUTLIER -150.9 137.17 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 114.018 -1.446 . . . . 0.0 107.178 179.598 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 39.8 t -92.15 54.89 2.46 Favored 'General case' 0 N--CA 1.507 2.385 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.906 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.578 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 9.3 m-30 -108.91 161.76 14.83 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.328 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 -89.65 41.7 1.05 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 55.39 37.16 28.49 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.978 -1.465 . . . . 0.0 110.86 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 171.68 -27.46 0.1 Allowed Glycine 0 N--CA 1.488 2.107 0 CA-C-N 114.754 -1.112 . . . . 0.0 114.038 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.7 tt -120.44 129.15 25.46 Favored Pre-proline 0 N--CA 1.498 1.953 0 CA-C-N 117.375 0.588 . . . . 0.0 111.433 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.578 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 16.9 Cg_endo . . . . . 0 C--N 1.316 -1.138 0 C-N-CA 122.354 2.036 . . . . 0.0 112.07 177.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -141.43 -89.64 0.15 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 175.64 -163.56 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 124.709 0.888 . . . . 0.0 112.385 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -49.49 129.87 19.52 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-N 114.575 -1.193 . . . . 0.0 114.203 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.535 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 0.8 OUTLIER -102.13 34.45 2.71 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 112.896 -1.956 . . . . 0.0 109.146 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.9 t -75.7 -67.29 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.171 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -67.91 -41.25 82.96 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.033 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.1 tp -147.62 125.86 6.04 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 124.504 1.128 . . . . 0.0 109.789 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -72.01 150.13 54.06 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.472 2.114 . . . . 0.0 111.432 177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -72.78 154.17 40.78 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.566 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.8 mt -117.59 -48.91 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.5 m -62.19 -41.93 98.8 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.785 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.93 -24.5 38.35 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.338 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.19 -44.78 53.15 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 123.984 0.802 . . . . 0.0 110.453 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.7 mt -91.8 45.61 1.23 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 124.416 1.073 . . . . 0.0 108.356 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.36 -98.19 0.11 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.0 m -82.75 -164.11 0.81 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.15 0.5 . . . . 0.0 112.167 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.5 t -146.65 158.54 43.92 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.922 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 t -97.39 120.79 38.4 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.506 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -155.2 135.31 13.04 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.289 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 49.66 68.52 0.72 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.568 1.168 . . . . 0.0 110.681 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.3 pttm 37.09 44.04 0.37 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 113.897 -1.501 . . . . 0.0 114.919 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.478 HG13 ' CG ' ' A' ' 25' ' ' TYR . 1.0 OUTLIER -151.27 131.69 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.934 179.599 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.535 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 5.5 m -95.46 42.85 1.09 Allowed 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.98 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.59 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 3.2 m-30 -104.62 162.59 13.14 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.52 33.99 0.9 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 113.618 -1.628 . . . . 0.0 108.298 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.0 m120 52.63 43.91 30.69 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.188 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 176.59 -22.16 0.05 OUTLIER Glycine 0 N--CA 1.488 2.116 0 CA-C-N 114.714 -1.13 . . . . 0.0 113.978 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -145.01 129.58 9.0 Favored Pre-proline 0 N--CA 1.5 2.051 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.59 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 15.2 Cg_endo . . . . . 0 N--CA 1.485 1.021 0 C-N-CA 122.214 1.942 . . . . 0.0 113.004 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' ' 26' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.52 -91.51 0.11 Allowed Glycine 0 N--CA 1.482 1.716 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 170.96 -167.66 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 124.828 0.957 . . . . 0.0 111.995 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.2 p -36.96 146.48 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.44 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -133.59 31.06 3.74 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 112.486 -2.143 . . . . 0.0 111.035 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.3 t -73.07 -49.72 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-N 114.27 -1.332 . . . . 0.0 108.891 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -71.73 -50.24 31.91 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.774 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 pt -144.13 132.01 10.76 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 124.385 1.053 . . . . 0.0 109.627 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -69.51 152.9 70.66 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.389 2.059 . . . . 0.0 111.873 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -67.49 148.22 51.8 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.334 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.5 mm -112.87 -56.49 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 124.302 1.001 . . . . 0.0 108.559 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 t -65.88 -42.59 90.11 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.068 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -78.97 -16.29 57.13 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 113.795 -1.548 . . . . 0.0 112.144 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.64 -45.78 14.18 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -83.84 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.599 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -53.37 -66.39 2.76 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -72.45 175.21 6.44 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 114.697 -0.752 . . . . 0.0 110.59 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.4 m -148.96 142.21 25.07 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.726 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 30.1 t -79.36 85.14 5.2 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.725 0.774 . . . . 0.0 109.899 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt -104.79 145.32 30.54 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.322 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.9 p30 39.78 56.03 2.42 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 124.61 1.194 . . . . 0.0 111.206 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt 41.18 44.11 2.11 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 113.234 -1.803 . . . . 0.0 113.627 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.1 t -150.21 134.09 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.44 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 51.5 m -92.04 73.47 5.55 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.826 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.485 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 11.9 m-30 -112.54 167.18 10.66 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 124.241 0.963 . . . . 0.0 109.867 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.429 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -117.15 89.51 3.13 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.2 m120 62.29 51.57 3.39 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.11 -1.405 . . . . 0.0 110.118 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.64 -2.86 71.22 Favored Glycine 0 N--CA 1.492 2.373 0 CA-C-N 114.042 -1.436 . . . . 0.0 115.781 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.74 130.28 43.61 Favored Pre-proline 0 N--CA 1.501 2.102 0 CA-C-N 118.131 0.966 . . . . 0.0 108.485 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.485 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 4.5 Cg_endo . . . . . 0 N--CA 1.487 1.139 0 C-N-CA 121.637 1.558 . . . . 0.0 112.09 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.417 ' HB2' ' HA ' ' A' ' 25' ' ' TYR . 1.3 m . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.29 -85.81 0.06 OUTLIER Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 177.75 -168.82 0.07 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 124.706 0.886 . . . . 0.0 111.11 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.8 m -45.92 147.32 1.01 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -131.18 33.56 4.12 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 112.207 -2.27 . . . . 0.0 109.306 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.29 -58.34 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.263 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -67.09 -54.78 18.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.265 0.978 . . . . 0.0 110.736 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.73 147.62 42.91 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 124.525 1.14 . . . . 0.0 110.406 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -72.51 156.71 53.82 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.924 2.416 . . . . 0.0 111.346 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.696 ' SG ' ' HB3' ' A' ' 13' ' ' ALA . 4.7 p -75.06 146.58 41.39 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.311 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.9 mt -94.28 -49.12 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 124.284 0.99 . . . . 0.0 110.213 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.4 m -66.03 -56.29 12.33 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.31 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.696 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -68.46 -4.49 15.08 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.483 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.25 -48.55 79.45 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.131 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.9 mt -82.58 74.94 9.51 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.17 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.64 -66.47 0.37 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.211 -1.955 . . . . 0.0 108.211 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.548 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -85.5 162.16 19.05 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 114.164 -1.018 . . . . 0.0 110.08 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.8 m -136.78 132.85 35.31 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.412 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 53.9 t -69.65 131.25 44.32 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.281 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -159.45 127.75 5.03 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.11 -1.405 . . . . 0.0 107.912 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 50.47 76.34 0.15 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.345 1.028 . . . . 0.0 112.614 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt 35.6 40.58 0.08 Allowed 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.518 HG13 ' CG ' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -150.77 135.86 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.2 56.55 0.64 Allowed 'General case' 0 N--CA 1.507 2.425 0 CA-C-O 122.459 1.123 . . . . 0.0 108.407 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.518 ' CG ' HG13 ' A' ' 23' ' ' VAL . 10.8 m-30 -95.63 172.05 8.29 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 112.739 -2.028 . . . . 0.0 111.791 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.416 ' HB3' HG22 ' A' ' 29' ' ' ILE . 30.6 ttt180 -93.46 39.55 1.06 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 55.48 39.83 31.15 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 113.797 -1.547 . . . . 0.0 111.486 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 169.43 -34.88 0.18 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 120.248 -0.977 . . . . 0.0 114.037 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.416 HG22 ' HB3' ' A' ' 26' ' ' ARG . 12.9 tt -117.62 137.61 24.39 Favored Pre-proline 0 N--CA 1.497 1.909 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.562 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.48 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 7.8 Cg_endo . . . . . 0 N--CA 1.487 1.132 0 C-N-CA 121.728 1.619 . . . . 0.0 110.384 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.02 -84.6 0.05 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 175.73 -167.72 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 O-C-N 124.682 0.872 . . . . 0.0 110.727 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 p -44.59 141.89 1.85 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.22 34.76 4.83 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 112.039 -2.346 . . . . 0.0 109.105 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.9 t -79.73 -68.35 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.347 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 41.6 t-105 -60.22 -43.74 95.77 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.894 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.0 tp -153.61 122.22 3.12 Favored Pre-proline 0 N--CA 1.487 1.398 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.099 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -71.12 146.31 51.56 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.365 2.043 . . . . 0.0 111.313 174.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.735 ' SG ' ' HB3' ' A' ' 13' ' ' ALA . 25.2 p -69.13 149.11 49.02 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.09 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.1 mm -104.75 -43.79 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 124.469 1.106 . . . . 0.0 109.147 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.8 m -70.42 -57.57 4.67 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.014 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.735 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -63.11 -24.36 67.86 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.851 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 10' ' ' CYS . . . -53.71 -27.87 30.64 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 123.484 0.49 . . . . 0.0 111.327 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 34.2 mt -67.53 -80.37 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 124.187 0.929 . . . . 0.0 110.02 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.4 -56.39 17.84 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.578 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -76.4 168.26 20.38 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.266 -0.967 . . . . 0.0 110.164 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.8 m -144.36 125.1 14.16 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.113 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 38.0 t -62.36 129.34 40.24 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.776 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.65 125.42 6.47 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.185 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 50.5 t30 49.08 73.88 0.21 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.58 1.175 . . . . 0.0 111.801 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt 36.01 47.49 0.44 Allowed 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.508 HG13 ' CG ' ' A' ' 25' ' ' TYR . 0.6 OUTLIER -150.99 130.9 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.39 45.8 0.95 Allowed 'General case' 0 N--CA 1.51 2.569 0 CA-C-O 122.44 1.114 . . . . 0.0 109.751 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.508 ' CG ' HG13 ' A' ' 23' ' ' VAL . 11.3 m-30 -90.2 169.63 10.98 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.06 -1.882 . . . . 0.0 110.859 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.405 ' HB3' HG22 ' A' ' 29' ' ' ILE . 7.2 ttm180 -90.71 36.85 0.9 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.7 m120 52.13 40.79 29.41 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.042 -1.435 . . . . 0.0 110.345 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.35 -26.76 0.09 OUTLIER Glycine 0 N--CA 1.486 2.021 0 CA-C-N 114.387 -1.279 . . . . 0.0 113.483 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.405 HG22 ' HB3' ' A' ' 26' ' ' ARG . 10.1 tt -128.01 133.25 24.92 Favored Pre-proline 0 N--CA 1.497 1.884 0 CA-C-N 117.204 0.502 . . . . 0.0 110.249 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.44 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 9.7 Cg_endo . . . . . 0 N--CA 1.489 1.213 0 C-N-CA 121.847 1.698 . . . . 0.0 109.876 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.54 -91.1 0.09 OUTLIER Glycine 0 N--CA 1.482 1.74 0 N-CA-C 106.936 -2.466 . . . . 0.0 106.936 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 171.8 -159.35 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 125.167 1.157 . . . . 0.0 110.318 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.9 p -35.66 141.72 0.08 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.66 31.08 3.71 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 111.749 -2.478 . . . . 0.0 108.725 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.3 t -72.05 -63.64 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-N 113.752 -1.567 . . . . 0.0 110.483 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.9 t-105 -66.66 -47.63 71.9 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.998 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.06 162.96 53.61 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 124.479 1.112 . . . . 0.0 110.85 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -67.18 164.89 28.54 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.559 2.173 . . . . 0.0 111.056 172.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.73 171.27 14.65 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.215 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.542 ' H ' HD12 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -95.93 -43.13 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.161 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.7 t -73.84 -104.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.376 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 64.94 -9.47 0.19 Allowed 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.79 -41.73 87.15 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 123.433 0.458 . . . . 0.0 109.922 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.1 mt -62.07 -33.2 73.96 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.167 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 128.08 27.13 0.95 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.6 m -65.15 109.79 2.31 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.336 0.588 . . . . 0.0 110.336 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.2 m -89.77 128.64 36.17 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 114.284 -1.325 . . . . 0.0 109.221 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 39.8 t -80.67 102.28 9.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 124.138 0.899 . . . . 0.0 110.599 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -138.06 145.98 42.41 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.889 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.8 m120 50.23 57.53 6.48 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.461 1.1 . . . . 0.0 110.544 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 pttt 38.76 42.69 0.64 Allowed 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 113.707 -1.588 . . . . 0.0 114.447 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.5 141.33 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 45.1 t -111.82 85.34 2.12 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.411 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.549 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 21.0 m-30 -119.89 168.56 10.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 124.618 1.198 . . . . 0.0 109.286 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.84 41.41 1.08 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 t30 55.36 42.62 29.98 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 113.648 -1.615 . . . . 0.0 112.037 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.65 -27.13 0.27 Allowed Glycine 0 N--CA 1.49 2.298 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.994 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.8 tt -121.39 138.07 27.72 Favored Pre-proline 0 N--CA 1.496 1.825 0 CA-C-O 119.348 -0.358 . . . . 0.0 110.06 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.549 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 9.4 Cg_endo . . . . . 0 C--N 1.315 -1.193 0 C-N-CA 121.529 1.486 . . . . 0.0 110.765 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 25' ' ' TYR . 1.1 m . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -144.01 -89.91 0.11 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 107.981 -2.048 . . . . 0.0 107.981 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 175.07 -167.56 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 124.788 0.934 . . . . 0.0 111.047 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 m -39.4 145.2 0.12 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -126.43 33.05 5.07 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 111.949 -2.387 . . . . 0.0 109.461 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.7 t -81.06 -69.65 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.625 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 45.9 t-105 -56.33 -41.93 76.86 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.958 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.1 tt -150.79 116.13 3.28 Favored Pre-proline 0 N--CA 1.485 1.322 0 CA-C-N 113.824 -1.535 . . . . 0.0 108.373 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -65.47 144.64 80.26 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.98 1.786 . . . . 0.0 110.738 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 p -63.38 152.97 36.6 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 124.245 0.966 . . . . 0.0 110.179 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.0 mm -110.18 -51.92 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 124.318 1.011 . . . . 0.0 109.767 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.6 m -70.02 -58.11 4.21 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.931 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.413 ' HB1' ' SG ' ' A' ' 17' ' ' CYS . . . -63.95 -11.31 27.3 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.575 -1.193 . . . . 0.0 112.089 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.18 -47.24 81.72 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 123.451 0.469 . . . . 0.0 110.874 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.75 -67.59 0.46 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.292 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.61 -70.62 0.92 Allowed Glycine 0 N--CA 1.494 2.547 0 O-C-N 124.233 0.958 . . . . 0.0 110.758 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.413 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -77.82 -173.67 3.17 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.687 -0.757 . . . . 0.0 109.049 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.0 m -149.21 129.36 13.61 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 123.372 0.42 . . . . 0.0 110.335 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 40.9 t -74.11 124.75 26.89 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.093 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.4 tttt -155.39 137.18 14.39 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.399 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.4 m120 50.48 61.85 2.99 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 124.277 0.986 . . . . 0.0 110.888 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 pttt 38.37 44.86 0.76 Allowed 'General case' 0 N--CA 1.502 2.164 0 CA-C-N 114.051 -1.432 . . . . 0.0 114.448 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.424 HG13 ' CG ' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -150.52 136.38 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 114.207 -1.36 . . . . 0.0 107.656 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 53.8 t -104.38 65.88 0.79 Allowed 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.009 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.527 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 16.9 m-30 -106.12 166.25 10.64 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.184 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.7 ptt85 -89.64 34.49 0.83 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.4 ' H ' ' C ' ' A' ' 25' ' ' TYR . 11.1 m120 50.65 51.14 17.51 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 113.587 -1.642 . . . . 0.0 110.541 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.25 -29.71 0.09 OUTLIER Glycine 0 N--CA 1.489 2.188 0 CA-C-N 114.347 -1.297 . . . . 0.0 113.274 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.09 146.9 20.91 Favored Pre-proline 0 N--CA 1.497 1.915 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.527 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 9.4 Cg_endo . . . . . 0 N--CA 1.488 1.163 0 C-N-CA 122.157 1.904 . . . . 0.0 111.476 -177.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 25' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.13 -90.02 0.09 OUTLIER Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.29 -167.34 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 O-C-N 125.02 1.071 . . . . 0.0 111.301 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 p -41.35 146.51 0.2 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.598 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 0.6 OUTLIER -125.41 29.54 6.01 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 111.29 -2.687 . . . . 0.0 109.989 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.78 -65.75 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-N 113.798 -1.547 . . . . 0.0 108.548 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -81.4 -41.56 21.73 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.265 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.3 pt -127.01 89.61 51.58 Favored Pre-proline 0 N--CA 1.486 1.353 0 O-C-N 124.664 1.227 . . . . 0.0 110.575 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -58.11 142.69 97.15 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.732 2.288 . . . . 0.0 112.444 173.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.435 ' O ' HD13 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -68.87 163.76 23.57 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.227 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.435 HD13 ' O ' ' A' ' 10' ' ' CYS . 18.3 mm -131.8 -58.96 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 t -69.36 -52.98 21.9 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.261 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.56 72.76 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.025 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.29 -28.18 40.27 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 123.584 0.553 . . . . 0.0 111.794 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.0 mt -72.49 -76.7 0.11 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.198 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.82 -60.55 7.92 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.69 179.87 5.77 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.174 -1.013 . . . . 0.0 108.63 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.4 m -146.7 131.3 17.81 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 123.475 0.484 . . . . 0.0 110.193 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 12.9 t -73.34 125.73 28.51 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.32 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.51 141.25 8.93 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 114.276 -1.329 . . . . 0.0 107.806 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.0 m120 53.91 54.47 9.72 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 124.301 1.001 . . . . 0.0 109.127 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt 38.67 45.2 0.87 Allowed 'General case' 0 N--CA 1.502 2.161 0 CA-C-N 113.618 -1.628 . . . . 0.0 113.984 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.527 HG13 ' CG ' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -150.72 139.51 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-N 114.39 -1.277 . . . . 0.0 107.899 179.683 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.598 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 61.7 m -99.68 59.92 1.1 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.527 ' CG ' HG13 ' A' ' 23' ' ' VAL . 10.9 m-30 -101.16 166.22 10.9 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.923 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.403 ' HB3' HG22 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -96.03 52.06 1.28 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 179.768 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.6 t30 51.49 37.77 20.33 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 113.564 -1.653 . . . . 0.0 112.937 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 164.03 -34.77 0.29 Allowed Glycine 0 N--CA 1.491 2.332 0 C-N-CA 120.134 -1.031 . . . . 0.0 114.502 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.403 HG22 ' HB3' ' A' ' 26' ' ' ARG . 15.3 tt -105.98 138.35 19.63 Favored Pre-proline 0 N--CA 1.498 1.959 0 CA-C-O 119.333 -0.365 . . . . 0.0 110.625 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.499 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 3.3 Cg_endo . . . . . 0 C--N 1.316 -1.141 0 C-N-CA 121.472 1.448 . . . . 0.0 109.371 170.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 25' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -147.15 -89.01 0.08 OUTLIER Glycine 0 N--CA 1.483 1.779 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 176.04 -171.43 0.07 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 124.92 1.012 . . . . 0.0 112.215 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.5 m -45.71 147.24 0.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.7 m -108.78 25.89 11.21 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 111.003 -2.817 . . . . 0.0 110.832 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.8 t -83.48 -66.56 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 113.999 -1.455 . . . . 0.0 109.15 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 30.3 t-105 -59.34 -41.82 90.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 124.356 1.035 . . . . 0.0 109.975 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.4 tt -162.54 124.25 1.61 Allowed Pre-proline 0 N--CA 1.485 1.311 0 CA-C-N 113.562 -1.654 . . . . 0.0 108.417 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -67.71 148.33 77.43 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.24 1.96 . . . . 0.0 110.092 171.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.408 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 1.7 p -67.85 173.77 4.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 124.064 0.852 . . . . 0.0 111.67 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.09 -58.36 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.0 p -66.09 -56.98 8.77 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.998 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.2 -32.31 73.67 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.491 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.59 -26.65 33.75 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 123.499 0.499 . . . . 0.0 112.037 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.0 mt -70.24 -75.4 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 123.824 0.703 . . . . 0.0 109.885 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.58 -57.82 14.85 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -76.9 -171.93 2.13 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 114.068 -1.066 . . . . 0.0 109.455 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.5 t -146.57 153.43 40.35 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.427 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.408 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 1.2 m -103.05 104.5 14.68 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.94 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -137.25 140.38 41.6 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.369 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 47.58 63.88 1.82 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 124.485 1.115 . . . . 0.0 110.806 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 38.27 45.94 0.84 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 114.178 -1.374 . . . . 0.0 114.139 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.468 HG13 ' CG ' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -150.97 132.53 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.598 179.647 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 37.3 t -100.86 68.44 1.29 Allowed 'General case' 0 N--CA 1.506 2.375 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.492 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 14.9 m-30 -111.19 160.24 17.13 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.915 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.407 ' O ' HG22 ' A' ' 29' ' ' ILE . 3.6 tmt_? -103.15 69.53 1.02 Allowed 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 64.76 77.49 0.31 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 113.295 -1.775 . . . . 0.0 111.434 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.86 -18.4 1.91 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 116.732 1.453 . . . . 0.0 116.732 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 26' ' ' ARG . 5.8 tp -89.83 128.15 51.32 Favored Pre-proline 0 N--CA 1.499 2.009 0 CA-C-N 118.349 1.075 . . . . 0.0 109.893 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.492 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 10.1 Cg_endo . . . . . 0 N--CA 1.488 1.155 0 C-N-CA 122.032 1.821 . . . . 0.0 111.396 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 25' ' ' TYR . 1.2 m . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.58 -88.05 0.08 OUTLIER Glycine 0 N--CA 1.485 1.946 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 174.91 -171.77 0.06 Allowed 'General case' 0 N--CA 1.503 2.202 0 O-C-N 124.867 0.98 . . . . 0.0 112.147 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.1 m -49.63 147.85 3.29 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.564 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 0.8 OUTLIER -127.54 36.49 4.37 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 112.077 -2.329 . . . . 0.0 110.484 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.0 t -66.69 -59.69 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.4 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 46.5 t-105 -67.79 -51.15 52.18 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.936 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.4 HD12 ' O ' ' A' ' 8' ' ' ILE . 1.1 pp -132.35 152.97 81.01 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 124.546 1.154 . . . . 0.0 110.546 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -74.41 167.95 25.94 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.854 2.369 . . . . 0.0 110.877 172.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.427 ' SG ' ' HB2' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -86.77 177.74 7.22 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.327 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.95 -74.77 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.5 m -63.6 -42.11 98.28 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.16 11.31 4.31 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.857 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.93 -51.07 5.24 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.3 -66.3 0.64 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.488 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.93 -75.39 0.31 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.05 -172.49 1.67 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.3 m -148.92 139.46 22.58 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.623 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.427 ' HB2' ' SG ' ' A' ' 10' ' ' CYS . 10.2 t -81.27 114.62 20.19 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.178 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -147.05 135.71 22.04 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.131 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.9 t30 48.98 68.16 0.76 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 124.525 1.14 . . . . 0.0 110.665 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? 38.33 42.25 0.51 Allowed 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.522 HG13 ' CG ' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -151.02 135.14 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.633 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.564 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 50.7 m -99.88 56.12 0.96 Allowed 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.522 ' CG ' HG13 ' A' ' 23' ' ' VAL . 10.4 m-30 -99.49 167.88 10.33 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.384 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.45 ' HB3' HG22 ' A' ' 29' ' ' ILE . 2.0 ttt85 -94.13 40.72 1.08 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 56.18 39.84 30.21 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.936 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.79 -34.26 0.19 Allowed Glycine 0 N--CA 1.488 2.143 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.875 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.45 HG22 ' HB3' ' A' ' 26' ' ' ARG . 13.8 tt -113.35 138.17 22.35 Favored Pre-proline 0 N--CA 1.498 1.972 0 CA-C-O 119.256 -0.402 . . . . 0.0 110.827 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.477 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 4.4 Cg_endo . . . . . 0 C--N 1.317 -1.113 0 C-N-CA 121.614 1.543 . . . . 0.0 109.353 171.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.98 -90.48 0.08 OUTLIER Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 172.02 -165.38 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 125.203 1.179 . . . . 0.0 110.248 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.1 m -41.61 146.43 0.23 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.85 34.79 1.58 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 111.647 -2.524 . . . . 0.0 108.218 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.5 t -70.16 -60.84 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.599 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -64.57 -49.88 69.45 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.297 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 pp -132.39 161.82 60.79 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 124.643 1.214 . . . . 0.0 110.722 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -66.34 152.54 80.77 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.32 2.013 . . . . 0.0 109.841 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.04 166.14 18.72 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 123.921 0.763 . . . . 0.0 112.207 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.0 mm -89.88 -36.91 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.88 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.6 t -80.13 -110.78 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.585 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 60.14 -2.18 0.16 Allowed 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.64 -32.62 60.3 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 123.486 0.491 . . . . 0.0 111.603 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.471 ' H ' HD12 ' A' ' 15' ' ' LEU . 5.3 mp -56.48 -36.75 69.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 124.161 0.913 . . . . 0.0 110.838 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.29 1.16 0.68 Allowed Glycine 0 N--CA 1.487 2.083 0 CA-C-N 114.205 -1.362 . . . . 0.0 109.939 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.29 150.49 43.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 123.933 0.431 . . . . 0.0 111.863 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.7 m -133.3 131.01 39.68 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.264 -1.335 . . . . 0.0 107.824 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.2 t -71.32 121.63 18.84 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.608 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.616 ' HZ1' ' H ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -157.63 145.71 18.98 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 113.859 -1.519 . . . . 0.0 108.466 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.0 m120 52.38 56.4 7.75 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 124.22 0.95 . . . . 0.0 109.857 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 pttt 38.44 39.5 0.3 Allowed 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 113.538 -1.665 . . . . 0.0 114.825 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -150.3 143.98 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 36.4 t -102.68 67.22 0.98 Allowed 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.77 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.488 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 14.7 m-30 -109.56 169.4 8.73 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.797 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.438 ' HB3' HG22 ' A' ' 29' ' ' ILE . 25.0 ttp180 -98.97 39.24 1.29 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.616 ' H ' ' HZ1' ' A' ' 20' ' ' LYS . 1.8 t30 55.9 44.05 26.44 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 113.398 -1.728 . . . . 0.0 110.519 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 165.41 -32.31 0.23 Allowed Glycine 0 N--CA 1.489 2.209 0 CA-C-N 114.843 -1.071 . . . . 0.0 113.481 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.438 HG22 ' HB3' ' A' ' 26' ' ' ARG . 14.1 tt -112.76 136.16 21.6 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 123.899 0.411 . . . . 0.0 110.058 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.488 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 9.8 Cg_endo . . . . . 0 C--N 1.314 -1.248 0 C-N-CA 121.625 1.55 . . . . 0.0 108.575 170.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.42 -88.55 0.07 OUTLIER Glycine 0 N--CA 1.483 1.821 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 174.79 -166.34 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.91 1.006 . . . . 0.0 110.892 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.9 m -42.57 146.52 0.34 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -135.11 44.78 2.57 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 111.266 -2.697 . . . . 0.0 108.113 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.8 t -80.55 -66.28 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 114.222 -1.354 . . . . 0.0 109.428 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.446 ' HB3' HD13 ' A' ' 8' ' ' ILE . 28.0 t-105 -67.04 -45.47 77.35 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.353 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.595 HD13 ' H ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -116.73 165.57 14.91 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 124.446 1.092 . . . . 0.0 109.607 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -74.86 -172.22 1.18 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.557 2.171 . . . . 0.0 109.802 165.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 37.4 m -76.22 -167.54 0.78 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.468 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.54 -57.58 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.424 ' C ' ' H ' ' A' ' 14' ' ' ALA . 68.9 m -59.27 -83.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.894 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 67.91 -15.12 0.21 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 123.879 0.737 . . . . 0.0 112.76 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.424 ' H ' ' C ' ' A' ' 12' ' ' SER . . . -67.81 -34.78 77.41 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mt -67.37 -5.4 14.34 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.586 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.1 23.82 53.94 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.39 160.53 32.19 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.332 0.586 . . . . 0.0 112.007 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.1 m -145.16 132.74 20.88 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.351 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.4 t -70.8 111.36 6.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 123.87 0.731 . . . . 0.0 110.564 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -138.54 130.56 28.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.365 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 t30 53.77 66.18 1.3 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 124.384 1.052 . . . . 0.0 111.355 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt 36.27 38.88 0.07 Allowed 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 114.057 -1.429 . . . . 0.0 114.71 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.428 HG13 ' CE1' ' A' ' 25' ' ' TYR . 2.8 t -150.4 136.04 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 49.3 t -103.98 80.95 1.8 Allowed 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.023 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.512 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 13.2 m-30 -114.45 169.76 8.81 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.159 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.521 ' HB3' HG22 ' A' ' 29' ' ' ILE . 7.2 ttp180 -95.03 42.11 1.09 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 55.86 41.51 29.98 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 113.913 -1.494 . . . . 0.0 111.51 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 162.27 -35.27 0.35 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.23 -0.986 . . . . 0.0 113.886 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.521 HG22 ' HB3' ' A' ' 26' ' ' ARG . 13.7 tt -110.12 138.95 20.95 Favored Pre-proline 0 N--CA 1.498 1.972 0 CA-C-O 119.227 -0.415 . . . . 0.0 110.094 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.512 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 7.7 Cg_endo . . . . . 0 C--N 1.314 -1.246 0 C-N-CA 121.408 1.405 . . . . 0.0 109.826 172.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.09 -87.25 0.06 OUTLIER Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 177.34 -165.78 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.551 0.795 . . . . 0.0 113.076 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.4 p -35.29 143.89 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 119.07 2.989 . . . . 0.0 119.07 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.8 m -110.82 19.3 18.71 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 110.831 -2.895 . . . . 0.0 110.166 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.0 t -79.3 -69.3 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-N 113.607 -1.633 . . . . 0.0 109.101 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -61.7 -38.33 87.44 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.964 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 tt -160.91 114.18 1.32 Allowed Pre-proline 0 N--CA 1.486 1.375 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.204 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.22 142.23 98.92 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.509 2.139 . . . . 0.0 110.229 166.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 p -66.12 176.55 1.68 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 114.805 -1.089 . . . . 0.0 112.594 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.73 -59.19 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.0 m -70.36 -53.24 17.42 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.338 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.08 -20.1 64.92 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.386 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.22 -27.77 68.23 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 123.804 0.69 . . . . 0.0 109.951 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mt -73.63 -56.18 5.34 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.78 -73.06 0.68 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.5 m -83.63 -176.79 6.46 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.535 -0.832 . . . . 0.0 109.892 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.6 m -128.67 168.88 15.15 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.719 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.0 m -104.53 99.98 9.66 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.15 140.66 47.72 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.399 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 48.64 58.32 5.38 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 124.179 0.924 . . . . 0.0 110.616 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.9 pttm 38.82 47.64 1.23 Allowed 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 114.031 -1.44 . . . . 0.0 113.665 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.561 HG13 ' CG ' ' A' ' 25' ' ' TYR . 0.4 OUTLIER -150.9 137.17 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 114.018 -1.446 . . . . 0.0 107.178 179.598 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 39.8 t -92.15 54.89 2.46 Favored 'General case' 0 N--CA 1.507 2.385 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.906 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.578 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 9.3 m-30 -108.91 161.76 14.83 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.328 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 -89.65 41.7 1.05 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 55.39 37.16 28.49 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.978 -1.465 . . . . 0.0 110.86 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 171.68 -27.46 0.1 Allowed Glycine 0 N--CA 1.488 2.107 0 CA-C-N 114.754 -1.112 . . . . 0.0 114.038 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.7 tt -120.44 129.15 25.46 Favored Pre-proline 0 N--CA 1.498 1.953 0 CA-C-N 117.375 0.588 . . . . 0.0 111.433 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.578 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 16.9 Cg_endo . . . . . 0 C--N 1.316 -1.138 0 C-N-CA 122.354 2.036 . . . . 0.0 112.07 177.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -141.43 -89.64 0.15 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 175.64 -163.56 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 124.709 0.888 . . . . 0.0 112.385 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -49.49 129.87 19.52 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-N 114.575 -1.193 . . . . 0.0 114.203 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.535 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 0.8 OUTLIER -102.13 34.45 2.71 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 112.896 -1.956 . . . . 0.0 109.146 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.9 t -75.7 -67.29 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.171 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -67.91 -41.25 82.96 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.033 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.1 tp -147.62 125.86 6.04 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 124.504 1.128 . . . . 0.0 109.789 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -72.01 150.13 54.06 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.472 2.114 . . . . 0.0 111.432 177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -72.78 154.17 40.78 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.566 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.8 mt -117.59 -48.91 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.5 m -62.19 -41.93 98.8 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.785 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.93 -24.5 38.35 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.338 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.19 -44.78 53.15 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 123.984 0.802 . . . . 0.0 110.453 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.7 mt -91.8 45.61 1.23 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 124.416 1.073 . . . . 0.0 108.356 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.36 -98.19 0.11 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.0 m -82.75 -164.11 0.81 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.15 0.5 . . . . 0.0 112.167 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.5 t -146.65 158.54 43.92 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.922 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 t -97.39 120.79 38.4 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.506 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -155.2 135.31 13.04 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.289 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 49.66 68.52 0.72 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.568 1.168 . . . . 0.0 110.681 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.3 pttm 37.09 44.04 0.37 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 113.897 -1.501 . . . . 0.0 114.919 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.478 HG13 ' CG ' ' A' ' 25' ' ' TYR . 1.0 OUTLIER -151.27 131.69 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.934 179.599 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.535 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 5.5 m -95.46 42.85 1.09 Allowed 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.98 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.59 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 3.2 m-30 -104.62 162.59 13.14 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.52 33.99 0.9 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 113.618 -1.628 . . . . 0.0 108.298 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.0 m120 52.63 43.91 30.69 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.188 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 176.59 -22.16 0.05 OUTLIER Glycine 0 N--CA 1.488 2.116 0 CA-C-N 114.714 -1.13 . . . . 0.0 113.978 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -145.01 129.58 9.0 Favored Pre-proline 0 N--CA 1.5 2.051 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.59 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 15.2 Cg_endo . . . . . 0 N--CA 1.485 1.021 0 C-N-CA 122.214 1.942 . . . . 0.0 113.004 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' ' 26' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.52 -91.51 0.11 Allowed Glycine 0 N--CA 1.482 1.716 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 170.96 -167.66 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 124.828 0.957 . . . . 0.0 111.995 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.2 p -36.96 146.48 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.44 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -133.59 31.06 3.74 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 112.486 -2.143 . . . . 0.0 111.035 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.3 t -73.07 -49.72 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-N 114.27 -1.332 . . . . 0.0 108.891 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -71.73 -50.24 31.91 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.774 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 pt -144.13 132.01 10.76 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 124.385 1.053 . . . . 0.0 109.627 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -69.51 152.9 70.66 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.389 2.059 . . . . 0.0 111.873 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -67.49 148.22 51.8 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.334 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.5 mm -112.87 -56.49 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 124.302 1.001 . . . . 0.0 108.559 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 t -65.88 -42.59 90.11 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.068 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -78.97 -16.29 57.13 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 113.795 -1.548 . . . . 0.0 112.144 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.64 -45.78 14.18 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -83.84 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.599 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -53.37 -66.39 2.76 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -72.45 175.21 6.44 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 114.697 -0.752 . . . . 0.0 110.59 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.4 m -148.96 142.21 25.07 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.726 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 30.1 t -79.36 85.14 5.2 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.725 0.774 . . . . 0.0 109.899 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt -104.79 145.32 30.54 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.322 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.9 p30 39.78 56.03 2.42 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 124.61 1.194 . . . . 0.0 111.206 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt 41.18 44.11 2.11 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 113.234 -1.803 . . . . 0.0 113.627 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.1 t -150.21 134.09 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.44 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 51.5 m -92.04 73.47 5.55 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.826 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.485 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 11.9 m-30 -112.54 167.18 10.66 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 124.241 0.963 . . . . 0.0 109.867 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.429 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -117.15 89.51 3.13 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.2 m120 62.29 51.57 3.39 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.11 -1.405 . . . . 0.0 110.118 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.64 -2.86 71.22 Favored Glycine 0 N--CA 1.492 2.373 0 CA-C-N 114.042 -1.436 . . . . 0.0 115.781 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.74 130.28 43.61 Favored Pre-proline 0 N--CA 1.501 2.102 0 CA-C-N 118.131 0.966 . . . . 0.0 108.485 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.485 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 4.5 Cg_endo . . . . . 0 N--CA 1.487 1.139 0 C-N-CA 121.637 1.558 . . . . 0.0 112.09 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.417 ' HB2' ' HA ' ' A' ' 25' ' ' TYR . 1.3 m . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.29 -85.81 0.06 OUTLIER Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 177.75 -168.82 0.07 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 124.706 0.886 . . . . 0.0 111.11 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.8 m -45.92 147.32 1.01 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -131.18 33.56 4.12 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 112.207 -2.27 . . . . 0.0 109.306 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.29 -58.34 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.263 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -67.09 -54.78 18.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.265 0.978 . . . . 0.0 110.736 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.73 147.62 42.91 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 124.525 1.14 . . . . 0.0 110.406 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -72.51 156.71 53.82 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.924 2.416 . . . . 0.0 111.346 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.696 ' SG ' ' HB3' ' A' ' 13' ' ' ALA . 4.7 p -75.06 146.58 41.39 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.311 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.9 mt -94.28 -49.12 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 124.284 0.99 . . . . 0.0 110.213 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.4 m -66.03 -56.29 12.33 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.31 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.696 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -68.46 -4.49 15.08 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.483 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.25 -48.55 79.45 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.131 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.9 mt -82.58 74.94 9.51 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.17 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.64 -66.47 0.37 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.211 -1.955 . . . . 0.0 108.211 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.548 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -85.5 162.16 19.05 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 114.164 -1.018 . . . . 0.0 110.08 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.8 m -136.78 132.85 35.31 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.412 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 53.9 t -69.65 131.25 44.32 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.281 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -159.45 127.75 5.03 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.11 -1.405 . . . . 0.0 107.912 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 50.47 76.34 0.15 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.345 1.028 . . . . 0.0 112.614 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt 35.6 40.58 0.08 Allowed 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.518 HG13 ' CG ' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -150.77 135.86 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.2 56.55 0.64 Allowed 'General case' 0 N--CA 1.507 2.425 0 CA-C-O 122.459 1.123 . . . . 0.0 108.407 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.518 ' CG ' HG13 ' A' ' 23' ' ' VAL . 10.8 m-30 -95.63 172.05 8.29 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 112.739 -2.028 . . . . 0.0 111.791 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.416 ' HB3' HG22 ' A' ' 29' ' ' ILE . 30.6 ttt180 -93.46 39.55 1.06 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 55.48 39.83 31.15 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 113.797 -1.547 . . . . 0.0 111.486 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 169.43 -34.88 0.18 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 120.248 -0.977 . . . . 0.0 114.037 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.416 HG22 ' HB3' ' A' ' 26' ' ' ARG . 12.9 tt -117.62 137.61 24.39 Favored Pre-proline 0 N--CA 1.497 1.909 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.562 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.48 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 7.8 Cg_endo . . . . . 0 N--CA 1.487 1.132 0 C-N-CA 121.728 1.619 . . . . 0.0 110.384 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.02 -84.6 0.05 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 175.73 -167.72 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 O-C-N 124.682 0.872 . . . . 0.0 110.727 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 p -44.59 141.89 1.85 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.22 34.76 4.83 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 112.039 -2.346 . . . . 0.0 109.105 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.9 t -79.73 -68.35 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.347 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 41.6 t-105 -60.22 -43.74 95.77 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.894 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.0 tp -153.61 122.22 3.12 Favored Pre-proline 0 N--CA 1.487 1.398 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.099 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -71.12 146.31 51.56 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.365 2.043 . . . . 0.0 111.313 174.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.735 ' SG ' ' HB3' ' A' ' 13' ' ' ALA . 25.2 p -69.13 149.11 49.02 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.09 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.1 mm -104.75 -43.79 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 124.469 1.106 . . . . 0.0 109.147 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.8 m -70.42 -57.57 4.67 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.014 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.735 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -63.11 -24.36 67.86 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.851 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 10' ' ' CYS . . . -53.71 -27.87 30.64 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 123.484 0.49 . . . . 0.0 111.327 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 34.2 mt -67.53 -80.37 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 124.187 0.929 . . . . 0.0 110.02 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.4 -56.39 17.84 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.578 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -76.4 168.26 20.38 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.266 -0.967 . . . . 0.0 110.164 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.8 m -144.36 125.1 14.16 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.113 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 38.0 t -62.36 129.34 40.24 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.776 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.65 125.42 6.47 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.185 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 50.5 t30 49.08 73.88 0.21 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.58 1.175 . . . . 0.0 111.801 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt 36.01 47.49 0.44 Allowed 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.508 HG13 ' CG ' ' A' ' 25' ' ' TYR . 0.6 OUTLIER -150.99 130.9 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.39 45.8 0.95 Allowed 'General case' 0 N--CA 1.51 2.569 0 CA-C-O 122.44 1.114 . . . . 0.0 109.751 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.508 ' CG ' HG13 ' A' ' 23' ' ' VAL . 11.3 m-30 -90.2 169.63 10.98 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.06 -1.882 . . . . 0.0 110.859 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.405 ' HB3' HG22 ' A' ' 29' ' ' ILE . 7.2 ttm180 -90.71 36.85 0.9 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.7 m120 52.13 40.79 29.41 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.042 -1.435 . . . . 0.0 110.345 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.35 -26.76 0.09 OUTLIER Glycine 0 N--CA 1.486 2.021 0 CA-C-N 114.387 -1.279 . . . . 0.0 113.483 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.405 HG22 ' HB3' ' A' ' 26' ' ' ARG . 10.1 tt -128.01 133.25 24.92 Favored Pre-proline 0 N--CA 1.497 1.884 0 CA-C-N 117.204 0.502 . . . . 0.0 110.249 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.44 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 9.7 Cg_endo . . . . . 0 N--CA 1.489 1.213 0 C-N-CA 121.847 1.698 . . . . 0.0 109.876 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.54 -91.1 0.09 OUTLIER Glycine 0 N--CA 1.482 1.74 0 N-CA-C 106.936 -2.466 . . . . 0.0 106.936 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 171.8 -159.35 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 125.167 1.157 . . . . 0.0 110.318 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.9 p -35.66 141.72 0.08 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.66 31.08 3.71 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 111.749 -2.478 . . . . 0.0 108.725 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.3 t -72.05 -63.64 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-N 113.752 -1.567 . . . . 0.0 110.483 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.9 t-105 -66.66 -47.63 71.9 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.998 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.06 162.96 53.61 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 124.479 1.112 . . . . 0.0 110.85 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -67.18 164.89 28.54 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.559 2.173 . . . . 0.0 111.056 172.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.73 171.27 14.65 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.215 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.542 ' H ' HD12 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -95.93 -43.13 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.161 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.7 t -73.84 -104.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.376 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 64.94 -9.47 0.19 Allowed 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.79 -41.73 87.15 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 123.433 0.458 . . . . 0.0 109.922 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.1 mt -62.07 -33.2 73.96 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.167 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 128.08 27.13 0.95 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.6 m -65.15 109.79 2.31 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.336 0.588 . . . . 0.0 110.336 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.2 m -89.77 128.64 36.17 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 114.284 -1.325 . . . . 0.0 109.221 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 39.8 t -80.67 102.28 9.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 124.138 0.899 . . . . 0.0 110.599 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -138.06 145.98 42.41 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.889 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.8 m120 50.23 57.53 6.48 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.461 1.1 . . . . 0.0 110.544 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 pttt 38.76 42.69 0.64 Allowed 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 113.707 -1.588 . . . . 0.0 114.447 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.5 141.33 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 45.1 t -111.82 85.34 2.12 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.411 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.549 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 21.0 m-30 -119.89 168.56 10.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 124.618 1.198 . . . . 0.0 109.286 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.84 41.41 1.08 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 t30 55.36 42.62 29.98 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 113.648 -1.615 . . . . 0.0 112.037 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.65 -27.13 0.27 Allowed Glycine 0 N--CA 1.49 2.298 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.994 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.8 tt -121.39 138.07 27.72 Favored Pre-proline 0 N--CA 1.496 1.825 0 CA-C-O 119.348 -0.358 . . . . 0.0 110.06 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.549 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 9.4 Cg_endo . . . . . 0 C--N 1.315 -1.193 0 C-N-CA 121.529 1.486 . . . . 0.0 110.765 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 25' ' ' TYR . 1.1 m . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -144.01 -89.91 0.11 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 107.981 -2.048 . . . . 0.0 107.981 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 175.07 -167.56 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 124.788 0.934 . . . . 0.0 111.047 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 m -39.4 145.2 0.12 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -126.43 33.05 5.07 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 111.949 -2.387 . . . . 0.0 109.461 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.7 t -81.06 -69.65 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.625 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 45.9 t-105 -56.33 -41.93 76.86 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.958 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.1 tt -150.79 116.13 3.28 Favored Pre-proline 0 N--CA 1.485 1.322 0 CA-C-N 113.824 -1.535 . . . . 0.0 108.373 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -65.47 144.64 80.26 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.98 1.786 . . . . 0.0 110.738 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 p -63.38 152.97 36.6 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 124.245 0.966 . . . . 0.0 110.179 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.0 mm -110.18 -51.92 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 124.318 1.011 . . . . 0.0 109.767 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.6 m -70.02 -58.11 4.21 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.931 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.413 ' HB1' ' SG ' ' A' ' 17' ' ' CYS . . . -63.95 -11.31 27.3 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.575 -1.193 . . . . 0.0 112.089 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.18 -47.24 81.72 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 123.451 0.469 . . . . 0.0 110.874 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.75 -67.59 0.46 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.292 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.61 -70.62 0.92 Allowed Glycine 0 N--CA 1.494 2.547 0 O-C-N 124.233 0.958 . . . . 0.0 110.758 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.413 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -77.82 -173.67 3.17 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.687 -0.757 . . . . 0.0 109.049 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.0 m -149.21 129.36 13.61 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 123.372 0.42 . . . . 0.0 110.335 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 40.9 t -74.11 124.75 26.89 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.093 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.4 tttt -155.39 137.18 14.39 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.399 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.4 m120 50.48 61.85 2.99 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 124.277 0.986 . . . . 0.0 110.888 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 pttt 38.37 44.86 0.76 Allowed 'General case' 0 N--CA 1.502 2.164 0 CA-C-N 114.051 -1.432 . . . . 0.0 114.448 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.424 HG13 ' CG ' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -150.52 136.38 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 114.207 -1.36 . . . . 0.0 107.656 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 53.8 t -104.38 65.88 0.79 Allowed 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.009 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.527 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 16.9 m-30 -106.12 166.25 10.64 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.184 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.7 ptt85 -89.64 34.49 0.83 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.4 ' H ' ' C ' ' A' ' 25' ' ' TYR . 11.1 m120 50.65 51.14 17.51 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 113.587 -1.642 . . . . 0.0 110.541 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.25 -29.71 0.09 OUTLIER Glycine 0 N--CA 1.489 2.188 0 CA-C-N 114.347 -1.297 . . . . 0.0 113.274 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.09 146.9 20.91 Favored Pre-proline 0 N--CA 1.497 1.915 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.527 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 9.4 Cg_endo . . . . . 0 N--CA 1.488 1.163 0 C-N-CA 122.157 1.904 . . . . 0.0 111.476 -177.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 25' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.13 -90.02 0.09 OUTLIER Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.29 -167.34 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 O-C-N 125.02 1.071 . . . . 0.0 111.301 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 p -41.35 146.51 0.2 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.598 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 0.6 OUTLIER -125.41 29.54 6.01 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 111.29 -2.687 . . . . 0.0 109.989 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.78 -65.75 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-N 113.798 -1.547 . . . . 0.0 108.548 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -81.4 -41.56 21.73 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.265 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.3 pt -127.01 89.61 51.58 Favored Pre-proline 0 N--CA 1.486 1.353 0 O-C-N 124.664 1.227 . . . . 0.0 110.575 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -58.11 142.69 97.15 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.732 2.288 . . . . 0.0 112.444 173.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.435 ' O ' HD13 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -68.87 163.76 23.57 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.227 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.435 HD13 ' O ' ' A' ' 10' ' ' CYS . 18.3 mm -131.8 -58.96 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 t -69.36 -52.98 21.9 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.261 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.56 72.76 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.025 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.29 -28.18 40.27 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 123.584 0.553 . . . . 0.0 111.794 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.0 mt -72.49 -76.7 0.11 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.198 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.82 -60.55 7.92 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.69 179.87 5.77 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.174 -1.013 . . . . 0.0 108.63 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.4 m -146.7 131.3 17.81 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 123.475 0.484 . . . . 0.0 110.193 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 12.9 t -73.34 125.73 28.51 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.32 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.51 141.25 8.93 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 114.276 -1.329 . . . . 0.0 107.806 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.0 m120 53.91 54.47 9.72 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 124.301 1.001 . . . . 0.0 109.127 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt 38.67 45.2 0.87 Allowed 'General case' 0 N--CA 1.502 2.161 0 CA-C-N 113.618 -1.628 . . . . 0.0 113.984 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.527 HG13 ' CG ' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -150.72 139.51 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-N 114.39 -1.277 . . . . 0.0 107.899 179.683 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.598 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 61.7 m -99.68 59.92 1.1 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.527 ' CG ' HG13 ' A' ' 23' ' ' VAL . 10.9 m-30 -101.16 166.22 10.9 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.923 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.403 ' HB3' HG22 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -96.03 52.06 1.28 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 179.768 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.6 t30 51.49 37.77 20.33 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 113.564 -1.653 . . . . 0.0 112.937 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 164.03 -34.77 0.29 Allowed Glycine 0 N--CA 1.491 2.332 0 C-N-CA 120.134 -1.031 . . . . 0.0 114.502 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.403 HG22 ' HB3' ' A' ' 26' ' ' ARG . 15.3 tt -105.98 138.35 19.63 Favored Pre-proline 0 N--CA 1.498 1.959 0 CA-C-O 119.333 -0.365 . . . . 0.0 110.625 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.499 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 3.3 Cg_endo . . . . . 0 C--N 1.316 -1.141 0 C-N-CA 121.472 1.448 . . . . 0.0 109.371 170.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 25' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -147.15 -89.01 0.08 OUTLIER Glycine 0 N--CA 1.483 1.779 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 176.04 -171.43 0.07 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 124.92 1.012 . . . . 0.0 112.215 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.5 m -45.71 147.24 0.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.7 m -108.78 25.89 11.21 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 111.003 -2.817 . . . . 0.0 110.832 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.8 t -83.48 -66.56 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 113.999 -1.455 . . . . 0.0 109.15 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 30.3 t-105 -59.34 -41.82 90.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 124.356 1.035 . . . . 0.0 109.975 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.4 tt -162.54 124.25 1.61 Allowed Pre-proline 0 N--CA 1.485 1.311 0 CA-C-N 113.562 -1.654 . . . . 0.0 108.417 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -67.71 148.33 77.43 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.24 1.96 . . . . 0.0 110.092 171.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.408 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 1.7 p -67.85 173.77 4.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 124.064 0.852 . . . . 0.0 111.67 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.09 -58.36 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.0 p -66.09 -56.98 8.77 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.998 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.2 -32.31 73.67 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.491 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.59 -26.65 33.75 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 123.499 0.499 . . . . 0.0 112.037 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.0 mt -70.24 -75.4 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 123.824 0.703 . . . . 0.0 109.885 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.58 -57.82 14.85 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -76.9 -171.93 2.13 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 114.068 -1.066 . . . . 0.0 109.455 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.5 t -146.57 153.43 40.35 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.427 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.408 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 1.2 m -103.05 104.5 14.68 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.94 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -137.25 140.38 41.6 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.369 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 47.58 63.88 1.82 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 124.485 1.115 . . . . 0.0 110.806 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 38.27 45.94 0.84 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 114.178 -1.374 . . . . 0.0 114.139 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.468 HG13 ' CG ' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -150.97 132.53 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.598 179.647 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 37.3 t -100.86 68.44 1.29 Allowed 'General case' 0 N--CA 1.506 2.375 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.492 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 14.9 m-30 -111.19 160.24 17.13 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.915 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.407 ' O ' HG22 ' A' ' 29' ' ' ILE . 3.6 tmt_? -103.15 69.53 1.02 Allowed 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 64.76 77.49 0.31 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 113.295 -1.775 . . . . 0.0 111.434 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.86 -18.4 1.91 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 116.732 1.453 . . . . 0.0 116.732 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 26' ' ' ARG . 5.8 tp -89.83 128.15 51.32 Favored Pre-proline 0 N--CA 1.499 2.009 0 CA-C-N 118.349 1.075 . . . . 0.0 109.893 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.492 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 10.1 Cg_endo . . . . . 0 N--CA 1.488 1.155 0 C-N-CA 122.032 1.821 . . . . 0.0 111.396 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 25' ' ' TYR . 1.2 m . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.58 -88.05 0.08 OUTLIER Glycine 0 N--CA 1.485 1.946 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 174.91 -171.77 0.06 Allowed 'General case' 0 N--CA 1.503 2.202 0 O-C-N 124.867 0.98 . . . . 0.0 112.147 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.1 m -49.63 147.85 3.29 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.564 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 0.8 OUTLIER -127.54 36.49 4.37 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 112.077 -2.329 . . . . 0.0 110.484 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.0 t -66.69 -59.69 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.4 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 46.5 t-105 -67.79 -51.15 52.18 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.936 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.4 HD12 ' O ' ' A' ' 8' ' ' ILE . 1.1 pp -132.35 152.97 81.01 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 124.546 1.154 . . . . 0.0 110.546 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -74.41 167.95 25.94 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.854 2.369 . . . . 0.0 110.877 172.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.427 ' SG ' ' HB2' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -86.77 177.74 7.22 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.327 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.95 -74.77 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.5 m -63.6 -42.11 98.28 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.16 11.31 4.31 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.857 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.93 -51.07 5.24 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.3 -66.3 0.64 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.488 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.93 -75.39 0.31 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.05 -172.49 1.67 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.3 m -148.92 139.46 22.58 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.623 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.427 ' HB2' ' SG ' ' A' ' 10' ' ' CYS . 10.2 t -81.27 114.62 20.19 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.178 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -147.05 135.71 22.04 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.131 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.9 t30 48.98 68.16 0.76 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 124.525 1.14 . . . . 0.0 110.665 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? 38.33 42.25 0.51 Allowed 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.522 HG13 ' CG ' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -151.02 135.14 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.633 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.564 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 50.7 m -99.88 56.12 0.96 Allowed 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.522 ' CG ' HG13 ' A' ' 23' ' ' VAL . 10.4 m-30 -99.49 167.88 10.33 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.384 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.45 ' HB3' HG22 ' A' ' 29' ' ' ILE . 2.0 ttt85 -94.13 40.72 1.08 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 56.18 39.84 30.21 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.936 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.79 -34.26 0.19 Allowed Glycine 0 N--CA 1.488 2.143 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.875 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.45 HG22 ' HB3' ' A' ' 26' ' ' ARG . 13.8 tt -113.35 138.17 22.35 Favored Pre-proline 0 N--CA 1.498 1.972 0 CA-C-O 119.256 -0.402 . . . . 0.0 110.827 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.477 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 4.4 Cg_endo . . . . . 0 C--N 1.317 -1.113 0 C-N-CA 121.614 1.543 . . . . 0.0 109.353 171.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.98 -90.48 0.08 OUTLIER Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 172.02 -165.38 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 125.203 1.179 . . . . 0.0 110.248 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.1 m -41.61 146.43 0.23 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.85 34.79 1.58 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 111.647 -2.524 . . . . 0.0 108.218 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.5 t -70.16 -60.84 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.599 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -64.57 -49.88 69.45 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.297 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 pp -132.39 161.82 60.79 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 124.643 1.214 . . . . 0.0 110.722 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -66.34 152.54 80.77 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.32 2.013 . . . . 0.0 109.841 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.04 166.14 18.72 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 123.921 0.763 . . . . 0.0 112.207 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.0 mm -89.88 -36.91 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.88 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.6 t -80.13 -110.78 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.585 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 60.14 -2.18 0.16 Allowed 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.64 -32.62 60.3 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 123.486 0.491 . . . . 0.0 111.603 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.471 ' H ' HD12 ' A' ' 15' ' ' LEU . 5.3 mp -56.48 -36.75 69.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 124.161 0.913 . . . . 0.0 110.838 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.29 1.16 0.68 Allowed Glycine 0 N--CA 1.487 2.083 0 CA-C-N 114.205 -1.362 . . . . 0.0 109.939 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.29 150.49 43.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 123.933 0.431 . . . . 0.0 111.863 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.7 m -133.3 131.01 39.68 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.264 -1.335 . . . . 0.0 107.824 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.2 t -71.32 121.63 18.84 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.608 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.616 ' HZ1' ' H ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -157.63 145.71 18.98 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 113.859 -1.519 . . . . 0.0 108.466 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.0 m120 52.38 56.4 7.75 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 124.22 0.95 . . . . 0.0 109.857 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 pttt 38.44 39.5 0.3 Allowed 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 113.538 -1.665 . . . . 0.0 114.825 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -150.3 143.98 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 36.4 t -102.68 67.22 0.98 Allowed 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.77 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.488 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 14.7 m-30 -109.56 169.4 8.73 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.797 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.438 ' HB3' HG22 ' A' ' 29' ' ' ILE . 25.0 ttp180 -98.97 39.24 1.29 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.616 ' H ' ' HZ1' ' A' ' 20' ' ' LYS . 1.8 t30 55.9 44.05 26.44 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 113.398 -1.728 . . . . 0.0 110.519 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 165.41 -32.31 0.23 Allowed Glycine 0 N--CA 1.489 2.209 0 CA-C-N 114.843 -1.071 . . . . 0.0 113.481 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.438 HG22 ' HB3' ' A' ' 26' ' ' ARG . 14.1 tt -112.76 136.16 21.6 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 123.899 0.411 . . . . 0.0 110.058 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.488 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 9.8 Cg_endo . . . . . 0 C--N 1.314 -1.248 0 C-N-CA 121.625 1.55 . . . . 0.0 108.575 170.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.42 -88.55 0.07 OUTLIER Glycine 0 N--CA 1.483 1.821 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 174.79 -166.34 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.91 1.006 . . . . 0.0 110.892 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.9 m -42.57 146.52 0.34 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -135.11 44.78 2.57 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 111.266 -2.697 . . . . 0.0 108.113 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.8 t -80.55 -66.28 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 114.222 -1.354 . . . . 0.0 109.428 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.446 ' HB3' HD13 ' A' ' 8' ' ' ILE . 28.0 t-105 -67.04 -45.47 77.35 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.353 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.595 HD13 ' H ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -116.73 165.57 14.91 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 124.446 1.092 . . . . 0.0 109.607 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -74.86 -172.22 1.18 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.557 2.171 . . . . 0.0 109.802 165.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 37.4 m -76.22 -167.54 0.78 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.468 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.54 -57.58 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.424 ' C ' ' H ' ' A' ' 14' ' ' ALA . 68.9 m -59.27 -83.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.894 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 67.91 -15.12 0.21 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 123.879 0.737 . . . . 0.0 112.76 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.424 ' H ' ' C ' ' A' ' 12' ' ' SER . . . -67.81 -34.78 77.41 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mt -67.37 -5.4 14.34 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.586 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.1 23.82 53.94 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.39 160.53 32.19 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.332 0.586 . . . . 0.0 112.007 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.1 m -145.16 132.74 20.88 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.351 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.4 t -70.8 111.36 6.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 123.87 0.731 . . . . 0.0 110.564 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -138.54 130.56 28.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.365 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 t30 53.77 66.18 1.3 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 124.384 1.052 . . . . 0.0 111.355 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt 36.27 38.88 0.07 Allowed 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 114.057 -1.429 . . . . 0.0 114.71 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.428 HG13 ' CE1' ' A' ' 25' ' ' TYR . 2.8 t -150.4 136.04 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 49.3 t -103.98 80.95 1.8 Allowed 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.023 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.512 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 13.2 m-30 -114.45 169.76 8.81 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.159 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.521 ' HB3' HG22 ' A' ' 29' ' ' ILE . 7.2 ttp180 -95.03 42.11 1.09 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 55.86 41.51 29.98 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 113.913 -1.494 . . . . 0.0 111.51 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 162.27 -35.27 0.35 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.23 -0.986 . . . . 0.0 113.886 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.521 HG22 ' HB3' ' A' ' 26' ' ' ARG . 13.7 tt -110.12 138.95 20.95 Favored Pre-proline 0 N--CA 1.498 1.972 0 CA-C-O 119.227 -0.415 . . . . 0.0 110.094 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.512 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 7.7 Cg_endo . . . . . 0 C--N 1.314 -1.246 0 C-N-CA 121.408 1.405 . . . . 0.0 109.826 172.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.09 -87.25 0.06 OUTLIER Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 177.34 -165.78 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.551 0.795 . . . . 0.0 113.076 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.4 p -35.29 143.89 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 119.07 2.989 . . . . 0.0 119.07 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.8 m -110.82 19.3 18.71 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 110.831 -2.895 . . . . 0.0 110.166 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.0 t -79.3 -69.3 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-N 113.607 -1.633 . . . . 0.0 109.101 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -61.7 -38.33 87.44 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.964 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 tt -160.91 114.18 1.32 Allowed Pre-proline 0 N--CA 1.486 1.375 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.204 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.22 142.23 98.92 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.509 2.139 . . . . 0.0 110.229 166.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 p -66.12 176.55 1.68 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 114.805 -1.089 . . . . 0.0 112.594 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.73 -59.19 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.0 m -70.36 -53.24 17.42 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.338 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.08 -20.1 64.92 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.386 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.22 -27.77 68.23 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 123.804 0.69 . . . . 0.0 109.951 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mt -73.63 -56.18 5.34 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.78 -73.06 0.68 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.5 m -83.63 -176.79 6.46 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.535 -0.832 . . . . 0.0 109.892 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.6 m -128.67 168.88 15.15 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.719 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.0 m -104.53 99.98 9.66 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.15 140.66 47.72 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.399 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 48.64 58.32 5.38 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 124.179 0.924 . . . . 0.0 110.616 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.9 pttm 38.82 47.64 1.23 Allowed 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 114.031 -1.44 . . . . 0.0 113.665 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.561 HG13 ' CG ' ' A' ' 25' ' ' TYR . 0.4 OUTLIER -150.9 137.17 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 114.018 -1.446 . . . . 0.0 107.178 179.598 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 39.8 t -92.15 54.89 2.46 Favored 'General case' 0 N--CA 1.507 2.385 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.906 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.578 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 9.3 m-30 -108.91 161.76 14.83 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.328 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 -89.65 41.7 1.05 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 55.39 37.16 28.49 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.978 -1.465 . . . . 0.0 110.86 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 171.68 -27.46 0.1 Allowed Glycine 0 N--CA 1.488 2.107 0 CA-C-N 114.754 -1.112 . . . . 0.0 114.038 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.7 tt -120.44 129.15 25.46 Favored Pre-proline 0 N--CA 1.498 1.953 0 CA-C-N 117.375 0.588 . . . . 0.0 111.433 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.578 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 16.9 Cg_endo . . . . . 0 C--N 1.316 -1.138 0 C-N-CA 122.354 2.036 . . . . 0.0 112.07 177.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -141.43 -89.64 0.15 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 175.64 -163.56 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 124.709 0.888 . . . . 0.0 112.385 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -49.49 129.87 19.52 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-N 114.575 -1.193 . . . . 0.0 114.203 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.535 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 0.8 OUTLIER -102.13 34.45 2.71 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 112.896 -1.956 . . . . 0.0 109.146 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.9 t -75.7 -67.29 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.171 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -67.91 -41.25 82.96 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.033 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.1 tp -147.62 125.86 6.04 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 124.504 1.128 . . . . 0.0 109.789 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -72.01 150.13 54.06 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.472 2.114 . . . . 0.0 111.432 177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -72.78 154.17 40.78 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.566 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.8 mt -117.59 -48.91 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.5 m -62.19 -41.93 98.8 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.785 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.93 -24.5 38.35 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.338 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.19 -44.78 53.15 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 123.984 0.802 . . . . 0.0 110.453 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.7 mt -91.8 45.61 1.23 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 124.416 1.073 . . . . 0.0 108.356 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.36 -98.19 0.11 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.0 m -82.75 -164.11 0.81 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.15 0.5 . . . . 0.0 112.167 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.5 t -146.65 158.54 43.92 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.922 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 t -97.39 120.79 38.4 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.506 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -155.2 135.31 13.04 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.289 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.66 68.52 0.72 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.568 1.168 . . . . 0.0 110.681 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.3 pttm 37.09 44.04 0.37 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 113.897 -1.501 . . . . 0.0 114.919 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.478 HG13 ' CG ' ' A' ' 25' ' ' TYR . 1.0 OUTLIER -151.27 131.69 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.934 179.599 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.535 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 5.5 m -95.46 42.85 1.09 Allowed 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.98 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.59 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 3.2 m-30 -104.62 162.59 13.14 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.52 33.99 0.9 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 113.618 -1.628 . . . . 0.0 108.298 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 52.63 43.91 30.69 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.188 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 176.59 -22.16 0.05 OUTLIER Glycine 0 N--CA 1.488 2.116 0 CA-C-N 114.714 -1.13 . . . . 0.0 113.978 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -145.01 129.58 9.0 Favored Pre-proline 0 N--CA 1.5 2.051 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.59 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 15.2 Cg_endo . . . . . 0 N--CA 1.485 1.021 0 C-N-CA 122.214 1.942 . . . . 0.0 113.004 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' ' 26' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.52 -91.51 0.11 Allowed Glycine 0 N--CA 1.482 1.716 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 170.96 -167.66 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 124.828 0.957 . . . . 0.0 111.995 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.2 p -36.96 146.48 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.44 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -133.59 31.06 3.74 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 112.486 -2.143 . . . . 0.0 111.035 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.3 t -73.07 -49.72 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-N 114.27 -1.332 . . . . 0.0 108.891 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -71.73 -50.24 31.91 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.774 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 pt -144.13 132.01 10.76 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 124.385 1.053 . . . . 0.0 109.627 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -69.51 152.9 70.66 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.389 2.059 . . . . 0.0 111.873 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -67.49 148.22 51.8 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.334 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.5 mm -112.87 -56.49 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 124.302 1.001 . . . . 0.0 108.559 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 t -65.88 -42.59 90.11 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.068 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -78.97 -16.29 57.13 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 113.795 -1.548 . . . . 0.0 112.144 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.64 -45.78 14.18 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -83.84 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.599 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -53.37 -66.39 2.76 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -72.45 175.21 6.44 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 114.697 -0.752 . . . . 0.0 110.59 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.4 m -148.96 142.21 25.07 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.726 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 30.1 t -79.36 85.14 5.2 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.725 0.774 . . . . 0.0 109.899 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt -104.79 145.32 30.54 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.322 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.9 p30 39.78 56.03 2.42 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 124.61 1.194 . . . . 0.0 111.206 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt 41.18 44.11 2.11 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 113.234 -1.803 . . . . 0.0 113.627 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.1 t -150.21 134.09 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.44 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 51.5 m -92.04 73.47 5.55 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.826 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.485 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 11.9 m-30 -112.54 167.18 10.66 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 124.241 0.963 . . . . 0.0 109.867 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.429 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -117.15 89.51 3.13 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 62.29 51.57 3.39 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.11 -1.405 . . . . 0.0 110.118 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.64 -2.86 71.22 Favored Glycine 0 N--CA 1.492 2.373 0 CA-C-N 114.042 -1.436 . . . . 0.0 115.781 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.74 130.28 43.61 Favored Pre-proline 0 N--CA 1.501 2.102 0 CA-C-N 118.131 0.966 . . . . 0.0 108.485 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.485 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 4.5 Cg_endo . . . . . 0 N--CA 1.487 1.139 0 C-N-CA 121.637 1.558 . . . . 0.0 112.09 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.417 ' HB2' ' HA ' ' A' ' 25' ' ' TYR . 1.3 m . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.29 -85.81 0.06 OUTLIER Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 177.75 -168.82 0.07 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 124.706 0.886 . . . . 0.0 111.11 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.8 m -45.92 147.32 1.01 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -131.18 33.56 4.12 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 112.207 -2.27 . . . . 0.0 109.306 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.29 -58.34 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.263 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -67.09 -54.78 18.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.265 0.978 . . . . 0.0 110.736 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.73 147.62 42.91 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 124.525 1.14 . . . . 0.0 110.406 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -72.51 156.71 53.82 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.924 2.416 . . . . 0.0 111.346 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.696 ' SG ' ' HB3' ' A' ' 13' ' ' ALA . 4.7 p -75.06 146.58 41.39 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.311 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.9 mt -94.28 -49.12 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 124.284 0.99 . . . . 0.0 110.213 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.4 m -66.03 -56.29 12.33 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.31 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.696 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -68.46 -4.49 15.08 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.483 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.25 -48.55 79.45 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.131 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.9 mt -82.58 74.94 9.51 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.17 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.64 -66.47 0.37 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.211 -1.955 . . . . 0.0 108.211 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.548 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -85.5 162.16 19.05 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 114.164 -1.018 . . . . 0.0 110.08 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.8 m -136.78 132.85 35.31 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.412 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 53.9 t -69.65 131.25 44.32 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.281 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -159.45 127.75 5.03 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.11 -1.405 . . . . 0.0 107.912 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 50.47 76.34 0.15 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.345 1.028 . . . . 0.0 112.614 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt 35.6 40.58 0.08 Allowed 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.518 HG13 ' CG ' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -150.77 135.86 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.2 56.55 0.64 Allowed 'General case' 0 N--CA 1.507 2.425 0 CA-C-O 122.459 1.123 . . . . 0.0 108.407 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.518 ' CG ' HG13 ' A' ' 23' ' ' VAL . 10.8 m-30 -95.63 172.05 8.29 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 112.739 -2.028 . . . . 0.0 111.791 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.416 ' HB3' HG22 ' A' ' 29' ' ' ILE . 30.6 ttt180 -93.46 39.55 1.06 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 55.48 39.83 31.15 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 113.797 -1.547 . . . . 0.0 111.486 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 169.43 -34.88 0.18 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 120.248 -0.977 . . . . 0.0 114.037 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.416 HG22 ' HB3' ' A' ' 26' ' ' ARG . 12.9 tt -117.62 137.61 24.39 Favored Pre-proline 0 N--CA 1.497 1.909 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.562 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.48 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 7.8 Cg_endo . . . . . 0 N--CA 1.487 1.132 0 C-N-CA 121.728 1.619 . . . . 0.0 110.384 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.02 -84.6 0.05 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 175.73 -167.72 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 O-C-N 124.682 0.872 . . . . 0.0 110.727 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 p -44.59 141.89 1.85 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.22 34.76 4.83 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 112.039 -2.346 . . . . 0.0 109.105 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.9 t -79.73 -68.35 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.347 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 41.6 t-105 -60.22 -43.74 95.77 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.894 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.0 tp -153.61 122.22 3.12 Favored Pre-proline 0 N--CA 1.487 1.398 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.099 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -71.12 146.31 51.56 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.365 2.043 . . . . 0.0 111.313 174.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.735 ' SG ' ' HB3' ' A' ' 13' ' ' ALA . 25.2 p -69.13 149.11 49.02 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.09 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.1 mm -104.75 -43.79 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 124.469 1.106 . . . . 0.0 109.147 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.8 m -70.42 -57.57 4.67 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.014 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.735 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -63.11 -24.36 67.86 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.851 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 10' ' ' CYS . . . -53.71 -27.87 30.64 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 123.484 0.49 . . . . 0.0 111.327 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 34.2 mt -67.53 -80.37 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 124.187 0.929 . . . . 0.0 110.02 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.4 -56.39 17.84 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.578 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -76.4 168.26 20.38 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.266 -0.967 . . . . 0.0 110.164 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.8 m -144.36 125.1 14.16 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.113 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 38.0 t -62.36 129.34 40.24 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.776 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.65 125.42 6.47 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.185 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 50.5 t30 49.08 73.88 0.21 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.58 1.175 . . . . 0.0 111.801 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt 36.01 47.49 0.44 Allowed 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.508 HG13 ' CG ' ' A' ' 25' ' ' TYR . 0.6 OUTLIER -150.99 130.9 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.39 45.8 0.95 Allowed 'General case' 0 N--CA 1.51 2.569 0 CA-C-O 122.44 1.114 . . . . 0.0 109.751 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.508 ' CG ' HG13 ' A' ' 23' ' ' VAL . 11.3 m-30 -90.2 169.63 10.98 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.06 -1.882 . . . . 0.0 110.859 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.405 ' HB3' HG22 ' A' ' 29' ' ' ILE . 7.2 ttm180 -90.71 36.85 0.9 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.7 m120 52.13 40.79 29.41 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.042 -1.435 . . . . 0.0 110.345 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.35 -26.76 0.09 OUTLIER Glycine 0 N--CA 1.486 2.021 0 CA-C-N 114.387 -1.279 . . . . 0.0 113.483 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.405 HG22 ' HB3' ' A' ' 26' ' ' ARG . 10.1 tt -128.01 133.25 24.92 Favored Pre-proline 0 N--CA 1.497 1.884 0 CA-C-N 117.204 0.502 . . . . 0.0 110.249 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.44 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 9.7 Cg_endo . . . . . 0 N--CA 1.489 1.213 0 C-N-CA 121.847 1.698 . . . . 0.0 109.876 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.54 -91.1 0.09 OUTLIER Glycine 0 N--CA 1.482 1.74 0 N-CA-C 106.936 -2.466 . . . . 0.0 106.936 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 171.8 -159.35 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 125.167 1.157 . . . . 0.0 110.318 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.9 p -35.66 141.72 0.08 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.66 31.08 3.71 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 111.749 -2.478 . . . . 0.0 108.725 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.3 t -72.05 -63.64 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-N 113.752 -1.567 . . . . 0.0 110.483 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.9 t-105 -66.66 -47.63 71.9 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.998 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.06 162.96 53.61 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 124.479 1.112 . . . . 0.0 110.85 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -67.18 164.89 28.54 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.559 2.173 . . . . 0.0 111.056 172.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.73 171.27 14.65 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.215 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.542 ' H ' HD12 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -95.93 -43.13 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.161 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.7 t -73.84 -104.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.376 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 64.94 -9.47 0.19 Allowed 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.79 -41.73 87.15 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 123.433 0.458 . . . . 0.0 109.922 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.1 mt -62.07 -33.2 73.96 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.167 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 128.08 27.13 0.95 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.6 m -65.15 109.79 2.31 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.336 0.588 . . . . 0.0 110.336 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.2 m -89.77 128.64 36.17 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 114.284 -1.325 . . . . 0.0 109.221 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 39.8 t -80.67 102.28 9.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 124.138 0.899 . . . . 0.0 110.599 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -138.06 145.98 42.41 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.889 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 50.23 57.53 6.48 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.461 1.1 . . . . 0.0 110.544 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 pttt 38.76 42.69 0.64 Allowed 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 113.707 -1.588 . . . . 0.0 114.447 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.5 141.33 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 45.1 t -111.82 85.34 2.12 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.411 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.549 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 21.0 m-30 -119.89 168.56 10.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 124.618 1.198 . . . . 0.0 109.286 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.84 41.41 1.08 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 t30 55.36 42.62 29.98 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 113.648 -1.615 . . . . 0.0 112.037 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.65 -27.13 0.27 Allowed Glycine 0 N--CA 1.49 2.298 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.994 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.8 tt -121.39 138.07 27.72 Favored Pre-proline 0 N--CA 1.496 1.825 0 CA-C-O 119.348 -0.358 . . . . 0.0 110.06 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.549 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 9.4 Cg_endo . . . . . 0 C--N 1.315 -1.193 0 C-N-CA 121.529 1.486 . . . . 0.0 110.765 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 25' ' ' TYR . 1.1 m . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -144.01 -89.91 0.11 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 107.981 -2.048 . . . . 0.0 107.981 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 175.07 -167.56 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 124.788 0.934 . . . . 0.0 111.047 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 m -39.4 145.2 0.12 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -126.43 33.05 5.07 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 111.949 -2.387 . . . . 0.0 109.461 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.7 t -81.06 -69.65 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.625 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 45.9 t-105 -56.33 -41.93 76.86 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.958 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.1 tt -150.79 116.13 3.28 Favored Pre-proline 0 N--CA 1.485 1.322 0 CA-C-N 113.824 -1.535 . . . . 0.0 108.373 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -65.47 144.64 80.26 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.98 1.786 . . . . 0.0 110.738 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 p -63.38 152.97 36.6 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 124.245 0.966 . . . . 0.0 110.179 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.0 mm -110.18 -51.92 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 124.318 1.011 . . . . 0.0 109.767 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.6 m -70.02 -58.11 4.21 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.931 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.413 ' HB1' ' SG ' ' A' ' 17' ' ' CYS . . . -63.95 -11.31 27.3 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.575 -1.193 . . . . 0.0 112.089 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.18 -47.24 81.72 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 123.451 0.469 . . . . 0.0 110.874 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.75 -67.59 0.46 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.292 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.61 -70.62 0.92 Allowed Glycine 0 N--CA 1.494 2.547 0 O-C-N 124.233 0.958 . . . . 0.0 110.758 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.413 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -77.82 -173.67 3.17 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.687 -0.757 . . . . 0.0 109.049 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.0 m -149.21 129.36 13.61 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 123.372 0.42 . . . . 0.0 110.335 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 40.9 t -74.11 124.75 26.89 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.093 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.4 tttt -155.39 137.18 14.39 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.399 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 50.48 61.85 2.99 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 124.277 0.986 . . . . 0.0 110.888 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 pttt 38.37 44.86 0.76 Allowed 'General case' 0 N--CA 1.502 2.164 0 CA-C-N 114.051 -1.432 . . . . 0.0 114.448 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.424 HG13 ' CG ' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -150.52 136.38 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 114.207 -1.36 . . . . 0.0 107.656 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 53.8 t -104.38 65.88 0.79 Allowed 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.009 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.527 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 16.9 m-30 -106.12 166.25 10.64 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.184 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.7 ptt85 -89.64 34.49 0.83 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.4 ' H ' ' C ' ' A' ' 25' ' ' TYR . 11.1 m120 50.65 51.14 17.51 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 113.587 -1.642 . . . . 0.0 110.541 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.25 -29.71 0.09 OUTLIER Glycine 0 N--CA 1.489 2.188 0 CA-C-N 114.347 -1.297 . . . . 0.0 113.274 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.09 146.9 20.91 Favored Pre-proline 0 N--CA 1.497 1.915 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.527 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 9.4 Cg_endo . . . . . 0 N--CA 1.488 1.163 0 C-N-CA 122.157 1.904 . . . . 0.0 111.476 -177.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 25' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.13 -90.02 0.09 OUTLIER Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.29 -167.34 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 O-C-N 125.02 1.071 . . . . 0.0 111.301 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 p -41.35 146.51 0.2 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.598 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 0.6 OUTLIER -125.41 29.54 6.01 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 111.29 -2.687 . . . . 0.0 109.989 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.78 -65.75 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-N 113.798 -1.547 . . . . 0.0 108.548 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -81.4 -41.56 21.73 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.265 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.3 pt -127.01 89.61 51.58 Favored Pre-proline 0 N--CA 1.486 1.353 0 O-C-N 124.664 1.227 . . . . 0.0 110.575 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -58.11 142.69 97.15 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.732 2.288 . . . . 0.0 112.444 173.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.435 ' O ' HD13 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -68.87 163.76 23.57 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.227 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.435 HD13 ' O ' ' A' ' 10' ' ' CYS . 18.3 mm -131.8 -58.96 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 t -69.36 -52.98 21.9 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.261 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.56 72.76 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.025 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.29 -28.18 40.27 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 123.584 0.553 . . . . 0.0 111.794 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.0 mt -72.49 -76.7 0.11 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.198 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.82 -60.55 7.92 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.69 179.87 5.77 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.174 -1.013 . . . . 0.0 108.63 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.4 m -146.7 131.3 17.81 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 123.475 0.484 . . . . 0.0 110.193 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 12.9 t -73.34 125.73 28.51 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.32 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.51 141.25 8.93 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 114.276 -1.329 . . . . 0.0 107.806 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.0 m120 53.91 54.47 9.72 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 124.301 1.001 . . . . 0.0 109.127 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt 38.67 45.2 0.87 Allowed 'General case' 0 N--CA 1.502 2.161 0 CA-C-N 113.618 -1.628 . . . . 0.0 113.984 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.527 HG13 ' CG ' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -150.72 139.51 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-N 114.39 -1.277 . . . . 0.0 107.899 179.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.598 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 61.7 m -99.68 59.92 1.1 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.527 ' CG ' HG13 ' A' ' 23' ' ' VAL . 10.9 m-30 -101.16 166.22 10.9 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.923 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.403 ' HB3' HG22 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -96.03 52.06 1.28 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 179.768 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.6 t30 51.49 37.77 20.33 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 113.564 -1.653 . . . . 0.0 112.937 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 164.03 -34.77 0.29 Allowed Glycine 0 N--CA 1.491 2.332 0 C-N-CA 120.134 -1.031 . . . . 0.0 114.502 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.403 HG22 ' HB3' ' A' ' 26' ' ' ARG . 15.3 tt -105.98 138.35 19.63 Favored Pre-proline 0 N--CA 1.498 1.959 0 CA-C-O 119.333 -0.365 . . . . 0.0 110.625 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.499 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 3.3 Cg_endo . . . . . 0 C--N 1.316 -1.141 0 C-N-CA 121.472 1.448 . . . . 0.0 109.371 170.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 25' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -147.15 -89.01 0.08 OUTLIER Glycine 0 N--CA 1.483 1.779 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 176.04 -171.43 0.07 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 124.92 1.012 . . . . 0.0 112.215 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.5 m -45.71 147.24 0.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.7 m -108.78 25.89 11.21 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 111.003 -2.817 . . . . 0.0 110.832 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.8 t -83.48 -66.56 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 113.999 -1.455 . . . . 0.0 109.15 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 30.3 t-105 -59.34 -41.82 90.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 124.356 1.035 . . . . 0.0 109.975 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.4 tt -162.54 124.25 1.61 Allowed Pre-proline 0 N--CA 1.485 1.311 0 CA-C-N 113.562 -1.654 . . . . 0.0 108.417 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -67.71 148.33 77.43 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.24 1.96 . . . . 0.0 110.092 171.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.408 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 1.7 p -67.85 173.77 4.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 124.064 0.852 . . . . 0.0 111.67 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.09 -58.36 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.0 p -66.09 -56.98 8.77 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.998 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.2 -32.31 73.67 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.491 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.59 -26.65 33.75 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 123.499 0.499 . . . . 0.0 112.037 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.0 mt -70.24 -75.4 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 123.824 0.703 . . . . 0.0 109.885 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.58 -57.82 14.85 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -76.9 -171.93 2.13 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 114.068 -1.066 . . . . 0.0 109.455 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.5 t -146.57 153.43 40.35 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.427 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.408 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 1.2 m -103.05 104.5 14.68 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.94 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -137.25 140.38 41.6 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.369 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 47.58 63.88 1.82 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 124.485 1.115 . . . . 0.0 110.806 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 38.27 45.94 0.84 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 114.178 -1.374 . . . . 0.0 114.139 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.468 HG13 ' CG ' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -150.97 132.53 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.598 179.647 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 37.3 t -100.86 68.44 1.29 Allowed 'General case' 0 N--CA 1.506 2.375 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.492 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 14.9 m-30 -111.19 160.24 17.13 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.915 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.407 ' O ' HG22 ' A' ' 29' ' ' ILE . 3.6 tmt_? -103.15 69.53 1.02 Allowed 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 64.76 77.49 0.31 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 113.295 -1.775 . . . . 0.0 111.434 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.86 -18.4 1.91 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 116.732 1.453 . . . . 0.0 116.732 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 26' ' ' ARG . 5.8 tp -89.83 128.15 51.32 Favored Pre-proline 0 N--CA 1.499 2.009 0 CA-C-N 118.349 1.075 . . . . 0.0 109.893 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.492 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 10.1 Cg_endo . . . . . 0 N--CA 1.488 1.155 0 C-N-CA 122.032 1.821 . . . . 0.0 111.396 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 25' ' ' TYR . 1.2 m . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.58 -88.05 0.08 OUTLIER Glycine 0 N--CA 1.485 1.946 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 174.91 -171.77 0.06 Allowed 'General case' 0 N--CA 1.503 2.202 0 O-C-N 124.867 0.98 . . . . 0.0 112.147 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.1 m -49.63 147.85 3.29 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.564 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 0.8 OUTLIER -127.54 36.49 4.37 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 112.077 -2.329 . . . . 0.0 110.484 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.0 t -66.69 -59.69 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.4 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 46.5 t-105 -67.79 -51.15 52.18 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.936 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.4 HD12 ' O ' ' A' ' 8' ' ' ILE . 1.1 pp -132.35 152.97 81.01 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 124.546 1.154 . . . . 0.0 110.546 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -74.41 167.95 25.94 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.854 2.369 . . . . 0.0 110.877 172.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.427 ' SG ' ' HB2' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -86.77 177.74 7.22 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.327 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.95 -74.77 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.5 m -63.6 -42.11 98.28 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.16 11.31 4.31 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.857 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.93 -51.07 5.24 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.3 -66.3 0.64 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.488 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.93 -75.39 0.31 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.05 -172.49 1.67 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.3 m -148.92 139.46 22.58 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.623 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.427 ' HB2' ' SG ' ' A' ' 10' ' ' CYS . 10.2 t -81.27 114.62 20.19 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.178 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -147.05 135.71 22.04 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.131 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.9 t30 48.98 68.16 0.76 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 124.525 1.14 . . . . 0.0 110.665 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? 38.33 42.25 0.51 Allowed 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.522 HG13 ' CG ' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -151.02 135.14 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.633 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.564 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 50.7 m -99.88 56.12 0.96 Allowed 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.522 ' CG ' HG13 ' A' ' 23' ' ' VAL . 10.4 m-30 -99.49 167.88 10.33 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.384 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.45 ' HB3' HG22 ' A' ' 29' ' ' ILE . 2.0 ttt85 -94.13 40.72 1.08 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 56.18 39.84 30.21 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.936 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.79 -34.26 0.19 Allowed Glycine 0 N--CA 1.488 2.143 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.875 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.45 HG22 ' HB3' ' A' ' 26' ' ' ARG . 13.8 tt -113.35 138.17 22.35 Favored Pre-proline 0 N--CA 1.498 1.972 0 CA-C-O 119.256 -0.402 . . . . 0.0 110.827 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.477 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 4.4 Cg_endo . . . . . 0 C--N 1.317 -1.113 0 C-N-CA 121.614 1.543 . . . . 0.0 109.353 171.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.98 -90.48 0.08 OUTLIER Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 172.02 -165.38 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 125.203 1.179 . . . . 0.0 110.248 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.1 m -41.61 146.43 0.23 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.85 34.79 1.58 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 111.647 -2.524 . . . . 0.0 108.218 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.5 t -70.16 -60.84 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.599 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -64.57 -49.88 69.45 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.297 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 pp -132.39 161.82 60.79 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 124.643 1.214 . . . . 0.0 110.722 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -66.34 152.54 80.77 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.32 2.013 . . . . 0.0 109.841 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.04 166.14 18.72 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 123.921 0.763 . . . . 0.0 112.207 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.0 mm -89.88 -36.91 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.88 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.6 t -80.13 -110.78 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.585 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 60.14 -2.18 0.16 Allowed 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.64 -32.62 60.3 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 123.486 0.491 . . . . 0.0 111.603 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.471 ' H ' HD12 ' A' ' 15' ' ' LEU . 5.3 mp -56.48 -36.75 69.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 124.161 0.913 . . . . 0.0 110.838 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.29 1.16 0.68 Allowed Glycine 0 N--CA 1.487 2.083 0 CA-C-N 114.205 -1.362 . . . . 0.0 109.939 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.29 150.49 43.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 123.933 0.431 . . . . 0.0 111.863 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.7 m -133.3 131.01 39.68 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.264 -1.335 . . . . 0.0 107.824 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.2 t -71.32 121.63 18.84 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.608 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.616 ' HZ1' ' H ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -157.63 145.71 18.98 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 113.859 -1.519 . . . . 0.0 108.466 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.0 m120 52.38 56.4 7.75 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 124.22 0.95 . . . . 0.0 109.857 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 pttt 38.44 39.5 0.3 Allowed 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 113.538 -1.665 . . . . 0.0 114.825 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -150.3 143.98 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 36.4 t -102.68 67.22 0.98 Allowed 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.77 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.488 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 14.7 m-30 -109.56 169.4 8.73 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.797 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.438 ' HB3' HG22 ' A' ' 29' ' ' ILE . 25.0 ttp180 -98.97 39.24 1.29 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.616 ' H ' ' HZ1' ' A' ' 20' ' ' LYS . 1.8 t30 55.9 44.05 26.44 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 113.398 -1.728 . . . . 0.0 110.519 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 165.41 -32.31 0.23 Allowed Glycine 0 N--CA 1.489 2.209 0 CA-C-N 114.843 -1.071 . . . . 0.0 113.481 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.438 HG22 ' HB3' ' A' ' 26' ' ' ARG . 14.1 tt -112.76 136.16 21.6 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 123.899 0.411 . . . . 0.0 110.058 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.488 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 9.8 Cg_endo . . . . . 0 C--N 1.314 -1.248 0 C-N-CA 121.625 1.55 . . . . 0.0 108.575 170.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.42 -88.55 0.07 OUTLIER Glycine 0 N--CA 1.483 1.821 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 174.79 -166.34 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.91 1.006 . . . . 0.0 110.892 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.9 m -42.57 146.52 0.34 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -135.11 44.78 2.57 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 111.266 -2.697 . . . . 0.0 108.113 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.8 t -80.55 -66.28 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 114.222 -1.354 . . . . 0.0 109.428 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.446 ' HB3' HD13 ' A' ' 8' ' ' ILE . 28.0 t-105 -67.04 -45.47 77.35 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.353 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.595 HD13 ' H ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -116.73 165.57 14.91 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 124.446 1.092 . . . . 0.0 109.607 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -74.86 -172.22 1.18 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.557 2.171 . . . . 0.0 109.802 165.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 37.4 m -76.22 -167.54 0.78 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.468 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.54 -57.58 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.424 ' C ' ' H ' ' A' ' 14' ' ' ALA . 68.9 m -59.27 -83.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.894 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 67.91 -15.12 0.21 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 123.879 0.737 . . . . 0.0 112.76 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.424 ' H ' ' C ' ' A' ' 12' ' ' SER . . . -67.81 -34.78 77.41 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mt -67.37 -5.4 14.34 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.586 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.1 23.82 53.94 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.39 160.53 32.19 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.332 0.586 . . . . 0.0 112.007 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.1 m -145.16 132.74 20.88 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.351 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.4 t -70.8 111.36 6.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 123.87 0.731 . . . . 0.0 110.564 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -138.54 130.56 28.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.365 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 t30 53.77 66.18 1.3 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 124.384 1.052 . . . . 0.0 111.355 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt 36.27 38.88 0.07 Allowed 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 114.057 -1.429 . . . . 0.0 114.71 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.428 HG13 ' CE1' ' A' ' 25' ' ' TYR . 2.8 t -150.4 136.04 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 49.3 t -103.98 80.95 1.8 Allowed 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.023 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.512 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 13.2 m-30 -114.45 169.76 8.81 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.159 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.521 ' HB3' HG22 ' A' ' 29' ' ' ILE . 7.2 ttp180 -95.03 42.11 1.09 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 55.86 41.51 29.98 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 113.913 -1.494 . . . . 0.0 111.51 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 162.27 -35.27 0.35 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.23 -0.986 . . . . 0.0 113.886 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.521 HG22 ' HB3' ' A' ' 26' ' ' ARG . 13.7 tt -110.12 138.95 20.95 Favored Pre-proline 0 N--CA 1.498 1.972 0 CA-C-O 119.227 -0.415 . . . . 0.0 110.094 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.512 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 7.7 Cg_endo . . . . . 0 C--N 1.314 -1.246 0 C-N-CA 121.408 1.405 . . . . 0.0 109.826 172.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.09 -87.25 0.06 OUTLIER Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 177.34 -165.78 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.551 0.795 . . . . 0.0 113.076 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.4 p -35.29 143.89 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 119.07 2.989 . . . . 0.0 119.07 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.8 m -110.82 19.3 18.71 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 110.831 -2.895 . . . . 0.0 110.166 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.0 t -79.3 -69.3 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-N 113.607 -1.633 . . . . 0.0 109.101 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -61.7 -38.33 87.44 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.964 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 tt -160.91 114.18 1.32 Allowed Pre-proline 0 N--CA 1.486 1.375 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.204 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.22 142.23 98.92 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.509 2.139 . . . . 0.0 110.229 166.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 p -66.12 176.55 1.68 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 114.805 -1.089 . . . . 0.0 112.594 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.73 -59.19 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.0 m -70.36 -53.24 17.42 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.338 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.08 -20.1 64.92 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.386 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.22 -27.77 68.23 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 123.804 0.69 . . . . 0.0 109.951 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mt -73.63 -56.18 5.34 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.78 -73.06 0.68 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.5 m -83.63 -176.79 6.46 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.535 -0.832 . . . . 0.0 109.892 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.6 m -128.67 168.88 15.15 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.719 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.0 m -104.53 99.98 9.66 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.15 140.66 47.72 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.399 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 48.64 58.32 5.38 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 124.179 0.924 . . . . 0.0 110.616 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.9 pttm 38.82 47.64 1.23 Allowed 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 114.031 -1.44 . . . . 0.0 113.665 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.561 HG13 ' CG ' ' A' ' 25' ' ' TYR . 0.4 OUTLIER -150.9 137.17 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 114.018 -1.446 . . . . 0.0 107.178 179.598 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 39.8 t -92.15 54.89 2.46 Favored 'General case' 0 N--CA 1.507 2.385 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.906 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.578 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 9.3 m-30 -108.91 161.76 14.83 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.328 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 -89.65 41.7 1.05 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 55.39 37.16 28.49 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.978 -1.465 . . . . 0.0 110.86 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 171.68 -27.46 0.1 Allowed Glycine 0 N--CA 1.488 2.107 0 CA-C-N 114.754 -1.112 . . . . 0.0 114.038 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.7 tt -120.44 129.15 25.46 Favored Pre-proline 0 N--CA 1.498 1.953 0 CA-C-N 117.375 0.588 . . . . 0.0 111.433 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.578 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 16.9 Cg_endo . . . . . 0 C--N 1.316 -1.138 0 C-N-CA 122.354 2.036 . . . . 0.0 112.07 177.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -141.43 -89.64 0.15 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 175.64 -163.56 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 124.709 0.888 . . . . 0.0 112.385 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -49.49 129.87 19.52 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-N 114.575 -1.193 . . . . 0.0 114.203 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.535 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 0.8 OUTLIER -102.13 34.45 2.71 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 112.896 -1.956 . . . . 0.0 109.146 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.9 t -75.7 -67.29 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.171 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -67.91 -41.25 82.96 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.033 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.1 tp -147.62 125.86 6.04 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 124.504 1.128 . . . . 0.0 109.789 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -72.01 150.13 54.06 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.472 2.114 . . . . 0.0 111.432 177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -72.78 154.17 40.78 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.566 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.8 mt -117.59 -48.91 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.5 m -62.19 -41.93 98.8 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.785 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.93 -24.5 38.35 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.338 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.19 -44.78 53.15 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 123.984 0.802 . . . . 0.0 110.453 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.7 mt -91.8 45.61 1.23 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 124.416 1.073 . . . . 0.0 108.356 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.36 -98.19 0.11 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.0 m -82.75 -164.11 0.81 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.15 0.5 . . . . 0.0 112.167 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.5 t -146.65 158.54 43.92 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.922 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 t -97.39 120.79 38.4 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.506 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -155.2 135.31 13.04 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.289 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.66 68.52 0.72 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.568 1.168 . . . . 0.0 110.681 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.3 pttm 37.09 44.04 0.37 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 113.897 -1.501 . . . . 0.0 114.919 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.478 HG13 ' CG ' ' A' ' 25' ' ' TYR . 1.0 OUTLIER -151.27 131.69 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.934 179.599 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.535 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 5.5 m -95.46 42.85 1.09 Allowed 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.98 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.59 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 3.2 m-30 -104.62 162.59 13.14 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.52 33.99 0.9 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 113.618 -1.628 . . . . 0.0 108.298 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 52.63 43.91 30.69 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.188 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 176.59 -22.16 0.05 OUTLIER Glycine 0 N--CA 1.488 2.116 0 CA-C-N 114.714 -1.13 . . . . 0.0 113.978 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -145.01 129.58 9.0 Favored Pre-proline 0 N--CA 1.5 2.051 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.59 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 15.2 Cg_endo . . . . . 0 N--CA 1.485 1.021 0 C-N-CA 122.214 1.942 . . . . 0.0 113.004 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' ' 26' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.52 -91.51 0.11 Allowed Glycine 0 N--CA 1.482 1.716 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 170.96 -167.66 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 124.828 0.957 . . . . 0.0 111.995 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.2 p -36.96 146.48 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.44 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -133.59 31.06 3.74 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 112.486 -2.143 . . . . 0.0 111.035 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.3 t -73.07 -49.72 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-N 114.27 -1.332 . . . . 0.0 108.891 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -71.73 -50.24 31.91 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.774 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 pt -144.13 132.01 10.76 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 124.385 1.053 . . . . 0.0 109.627 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -69.51 152.9 70.66 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.389 2.059 . . . . 0.0 111.873 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -67.49 148.22 51.8 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.334 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.5 mm -112.87 -56.49 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 124.302 1.001 . . . . 0.0 108.559 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 t -65.88 -42.59 90.11 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.068 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -78.97 -16.29 57.13 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 113.795 -1.548 . . . . 0.0 112.144 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.64 -45.78 14.18 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -83.84 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.599 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -53.37 -66.39 2.76 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -72.45 175.21 6.44 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 114.697 -0.752 . . . . 0.0 110.59 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.4 m -148.96 142.21 25.07 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.726 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 30.1 t -79.36 85.14 5.2 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.725 0.774 . . . . 0.0 109.899 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt -104.79 145.32 30.54 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.322 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.9 p30 39.78 56.03 2.42 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 124.61 1.194 . . . . 0.0 111.206 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt 41.18 44.11 2.11 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 113.234 -1.803 . . . . 0.0 113.627 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.1 t -150.21 134.09 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.44 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 51.5 m -92.04 73.47 5.55 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.826 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.485 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 11.9 m-30 -112.54 167.18 10.66 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 124.241 0.963 . . . . 0.0 109.867 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.429 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -117.15 89.51 3.13 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 62.29 51.57 3.39 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.11 -1.405 . . . . 0.0 110.118 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.64 -2.86 71.22 Favored Glycine 0 N--CA 1.492 2.373 0 CA-C-N 114.042 -1.436 . . . . 0.0 115.781 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.74 130.28 43.61 Favored Pre-proline 0 N--CA 1.501 2.102 0 CA-C-N 118.131 0.966 . . . . 0.0 108.485 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.485 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 4.5 Cg_endo . . . . . 0 N--CA 1.487 1.139 0 C-N-CA 121.637 1.558 . . . . 0.0 112.09 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.417 ' HB2' ' HA ' ' A' ' 25' ' ' TYR . 1.3 m . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.29 -85.81 0.06 OUTLIER Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 177.75 -168.82 0.07 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 124.706 0.886 . . . . 0.0 111.11 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.8 m -45.92 147.32 1.01 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -131.18 33.56 4.12 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 112.207 -2.27 . . . . 0.0 109.306 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.29 -58.34 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.263 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -67.09 -54.78 18.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.265 0.978 . . . . 0.0 110.736 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.73 147.62 42.91 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 124.525 1.14 . . . . 0.0 110.406 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -72.51 156.71 53.82 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.924 2.416 . . . . 0.0 111.346 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.696 ' SG ' ' HB3' ' A' ' 13' ' ' ALA . 4.7 p -75.06 146.58 41.39 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.311 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.9 mt -94.28 -49.12 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 124.284 0.99 . . . . 0.0 110.213 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.4 m -66.03 -56.29 12.33 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.31 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.696 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -68.46 -4.49 15.08 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.483 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.25 -48.55 79.45 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.131 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.9 mt -82.58 74.94 9.51 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.17 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.64 -66.47 0.37 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.211 -1.955 . . . . 0.0 108.211 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.548 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -85.5 162.16 19.05 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 114.164 -1.018 . . . . 0.0 110.08 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.8 m -136.78 132.85 35.31 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.412 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 53.9 t -69.65 131.25 44.32 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.281 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -159.45 127.75 5.03 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.11 -1.405 . . . . 0.0 107.912 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 50.47 76.34 0.15 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.345 1.028 . . . . 0.0 112.614 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt 35.6 40.58 0.08 Allowed 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.518 HG13 ' CG ' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -150.77 135.86 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.2 56.55 0.64 Allowed 'General case' 0 N--CA 1.507 2.425 0 CA-C-O 122.459 1.123 . . . . 0.0 108.407 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.518 ' CG ' HG13 ' A' ' 23' ' ' VAL . 10.8 m-30 -95.63 172.05 8.29 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 112.739 -2.028 . . . . 0.0 111.791 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.416 ' HB3' HG22 ' A' ' 29' ' ' ILE . 30.6 ttt180 -93.46 39.55 1.06 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 55.48 39.83 31.15 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 113.797 -1.547 . . . . 0.0 111.486 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 169.43 -34.88 0.18 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 120.248 -0.977 . . . . 0.0 114.037 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.416 HG22 ' HB3' ' A' ' 26' ' ' ARG . 12.9 tt -117.62 137.61 24.39 Favored Pre-proline 0 N--CA 1.497 1.909 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.562 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.48 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 7.8 Cg_endo . . . . . 0 N--CA 1.487 1.132 0 C-N-CA 121.728 1.619 . . . . 0.0 110.384 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.02 -84.6 0.05 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 175.73 -167.72 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 O-C-N 124.682 0.872 . . . . 0.0 110.727 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 p -44.59 141.89 1.85 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.22 34.76 4.83 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 112.039 -2.346 . . . . 0.0 109.105 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.9 t -79.73 -68.35 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.347 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 41.6 t-105 -60.22 -43.74 95.77 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.894 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.0 tp -153.61 122.22 3.12 Favored Pre-proline 0 N--CA 1.487 1.398 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.099 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -71.12 146.31 51.56 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.365 2.043 . . . . 0.0 111.313 174.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.735 ' SG ' ' HB3' ' A' ' 13' ' ' ALA . 25.2 p -69.13 149.11 49.02 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.09 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.1 mm -104.75 -43.79 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 124.469 1.106 . . . . 0.0 109.147 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.8 m -70.42 -57.57 4.67 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.014 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.735 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -63.11 -24.36 67.86 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.851 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 10' ' ' CYS . . . -53.71 -27.87 30.64 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 123.484 0.49 . . . . 0.0 111.327 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 34.2 mt -67.53 -80.37 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 124.187 0.929 . . . . 0.0 110.02 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.4 -56.39 17.84 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.578 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -76.4 168.26 20.38 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.266 -0.967 . . . . 0.0 110.164 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.8 m -144.36 125.1 14.16 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.113 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 38.0 t -62.36 129.34 40.24 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.776 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.65 125.42 6.47 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.185 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 50.5 t30 49.08 73.88 0.21 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.58 1.175 . . . . 0.0 111.801 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt 36.01 47.49 0.44 Allowed 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.508 HG13 ' CG ' ' A' ' 25' ' ' TYR . 0.6 OUTLIER -150.99 130.9 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.39 45.8 0.95 Allowed 'General case' 0 N--CA 1.51 2.569 0 CA-C-O 122.44 1.114 . . . . 0.0 109.751 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.508 ' CG ' HG13 ' A' ' 23' ' ' VAL . 11.3 m-30 -90.2 169.63 10.98 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.06 -1.882 . . . . 0.0 110.859 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.405 ' HB3' HG22 ' A' ' 29' ' ' ILE . 7.2 ttm180 -90.71 36.85 0.9 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.7 m120 52.13 40.79 29.41 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.042 -1.435 . . . . 0.0 110.345 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.35 -26.76 0.09 OUTLIER Glycine 0 N--CA 1.486 2.021 0 CA-C-N 114.387 -1.279 . . . . 0.0 113.483 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.405 HG22 ' HB3' ' A' ' 26' ' ' ARG . 10.1 tt -128.01 133.25 24.92 Favored Pre-proline 0 N--CA 1.497 1.884 0 CA-C-N 117.204 0.502 . . . . 0.0 110.249 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.44 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 9.7 Cg_endo . . . . . 0 N--CA 1.489 1.213 0 C-N-CA 121.847 1.698 . . . . 0.0 109.876 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.54 -91.1 0.09 OUTLIER Glycine 0 N--CA 1.482 1.74 0 N-CA-C 106.936 -2.466 . . . . 0.0 106.936 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 171.8 -159.35 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 125.167 1.157 . . . . 0.0 110.318 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.9 p -35.66 141.72 0.08 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.66 31.08 3.71 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 111.749 -2.478 . . . . 0.0 108.725 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.3 t -72.05 -63.64 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-N 113.752 -1.567 . . . . 0.0 110.483 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.9 t-105 -66.66 -47.63 71.9 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.998 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.06 162.96 53.61 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 124.479 1.112 . . . . 0.0 110.85 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -67.18 164.89 28.54 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.559 2.173 . . . . 0.0 111.056 172.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.73 171.27 14.65 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.215 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.542 ' H ' HD12 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -95.93 -43.13 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.161 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.7 t -73.84 -104.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.376 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 64.94 -9.47 0.19 Allowed 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.79 -41.73 87.15 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 123.433 0.458 . . . . 0.0 109.922 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.1 mt -62.07 -33.2 73.96 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.167 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 128.08 27.13 0.95 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.6 m -65.15 109.79 2.31 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.336 0.588 . . . . 0.0 110.336 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.2 m -89.77 128.64 36.17 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 114.284 -1.325 . . . . 0.0 109.221 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 39.8 t -80.67 102.28 9.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 124.138 0.899 . . . . 0.0 110.599 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -138.06 145.98 42.41 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.889 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 50.23 57.53 6.48 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.461 1.1 . . . . 0.0 110.544 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 pttt 38.76 42.69 0.64 Allowed 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 113.707 -1.588 . . . . 0.0 114.447 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.5 141.33 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 45.1 t -111.82 85.34 2.12 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.411 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.549 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 21.0 m-30 -119.89 168.56 10.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 124.618 1.198 . . . . 0.0 109.286 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.84 41.41 1.08 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 t30 55.36 42.62 29.98 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 113.648 -1.615 . . . . 0.0 112.037 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.65 -27.13 0.27 Allowed Glycine 0 N--CA 1.49 2.298 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.994 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.8 tt -121.39 138.07 27.72 Favored Pre-proline 0 N--CA 1.496 1.825 0 CA-C-O 119.348 -0.358 . . . . 0.0 110.06 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.549 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 9.4 Cg_endo . . . . . 0 C--N 1.315 -1.193 0 C-N-CA 121.529 1.486 . . . . 0.0 110.765 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 25' ' ' TYR . 1.1 m . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -144.01 -89.91 0.11 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 107.981 -2.048 . . . . 0.0 107.981 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 175.07 -167.56 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 124.788 0.934 . . . . 0.0 111.047 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 m -39.4 145.2 0.12 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -126.43 33.05 5.07 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 111.949 -2.387 . . . . 0.0 109.461 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.7 t -81.06 -69.65 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.625 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 45.9 t-105 -56.33 -41.93 76.86 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.958 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.1 tt -150.79 116.13 3.28 Favored Pre-proline 0 N--CA 1.485 1.322 0 CA-C-N 113.824 -1.535 . . . . 0.0 108.373 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -65.47 144.64 80.26 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.98 1.786 . . . . 0.0 110.738 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 p -63.38 152.97 36.6 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 124.245 0.966 . . . . 0.0 110.179 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.0 mm -110.18 -51.92 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 124.318 1.011 . . . . 0.0 109.767 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.6 m -70.02 -58.11 4.21 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.931 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.413 ' HB1' ' SG ' ' A' ' 17' ' ' CYS . . . -63.95 -11.31 27.3 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.575 -1.193 . . . . 0.0 112.089 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.18 -47.24 81.72 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 123.451 0.469 . . . . 0.0 110.874 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.75 -67.59 0.46 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.292 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.61 -70.62 0.92 Allowed Glycine 0 N--CA 1.494 2.547 0 O-C-N 124.233 0.958 . . . . 0.0 110.758 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.413 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -77.82 -173.67 3.17 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.687 -0.757 . . . . 0.0 109.049 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.0 m -149.21 129.36 13.61 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 123.372 0.42 . . . . 0.0 110.335 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 40.9 t -74.11 124.75 26.89 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.093 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.4 tttt -155.39 137.18 14.39 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.399 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 50.48 61.85 2.99 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 124.277 0.986 . . . . 0.0 110.888 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 pttt 38.37 44.86 0.76 Allowed 'General case' 0 N--CA 1.502 2.164 0 CA-C-N 114.051 -1.432 . . . . 0.0 114.448 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.424 HG13 ' CG ' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -150.52 136.38 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 114.207 -1.36 . . . . 0.0 107.656 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 53.8 t -104.38 65.88 0.79 Allowed 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.009 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.527 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 16.9 m-30 -106.12 166.25 10.64 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.184 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.7 ptt85 -89.64 34.49 0.83 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.4 ' H ' ' C ' ' A' ' 25' ' ' TYR . 11.1 m120 50.65 51.14 17.51 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 113.587 -1.642 . . . . 0.0 110.541 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.25 -29.71 0.09 OUTLIER Glycine 0 N--CA 1.489 2.188 0 CA-C-N 114.347 -1.297 . . . . 0.0 113.274 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.09 146.9 20.91 Favored Pre-proline 0 N--CA 1.497 1.915 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.527 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 9.4 Cg_endo . . . . . 0 N--CA 1.488 1.163 0 C-N-CA 122.157 1.904 . . . . 0.0 111.476 -177.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 25' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.13 -90.02 0.09 OUTLIER Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.29 -167.34 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 O-C-N 125.02 1.071 . . . . 0.0 111.301 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 p -41.35 146.51 0.2 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.598 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 0.6 OUTLIER -125.41 29.54 6.01 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 111.29 -2.687 . . . . 0.0 109.989 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.78 -65.75 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-N 113.798 -1.547 . . . . 0.0 108.548 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -81.4 -41.56 21.73 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.265 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.3 pt -127.01 89.61 51.58 Favored Pre-proline 0 N--CA 1.486 1.353 0 O-C-N 124.664 1.227 . . . . 0.0 110.575 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -58.11 142.69 97.15 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.732 2.288 . . . . 0.0 112.444 173.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.435 ' O ' HD13 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -68.87 163.76 23.57 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.227 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.435 HD13 ' O ' ' A' ' 10' ' ' CYS . 18.3 mm -131.8 -58.96 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 t -69.36 -52.98 21.9 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.261 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.56 72.76 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.025 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.29 -28.18 40.27 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 123.584 0.553 . . . . 0.0 111.794 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.0 mt -72.49 -76.7 0.11 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.198 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.82 -60.55 7.92 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.69 179.87 5.77 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.174 -1.013 . . . . 0.0 108.63 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.4 m -146.7 131.3 17.81 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 123.475 0.484 . . . . 0.0 110.193 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 12.9 t -73.34 125.73 28.51 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.32 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.51 141.25 8.93 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 114.276 -1.329 . . . . 0.0 107.806 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.0 m120 53.91 54.47 9.72 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 124.301 1.001 . . . . 0.0 109.127 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt 38.67 45.2 0.87 Allowed 'General case' 0 N--CA 1.502 2.161 0 CA-C-N 113.618 -1.628 . . . . 0.0 113.984 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.527 HG13 ' CG ' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -150.72 139.51 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-N 114.39 -1.277 . . . . 0.0 107.899 179.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.598 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 61.7 m -99.68 59.92 1.1 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.527 ' CG ' HG13 ' A' ' 23' ' ' VAL . 10.9 m-30 -101.16 166.22 10.9 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.923 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.403 ' HB3' HG22 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -96.03 52.06 1.28 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 179.768 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.6 t30 51.49 37.77 20.33 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 113.564 -1.653 . . . . 0.0 112.937 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 164.03 -34.77 0.29 Allowed Glycine 0 N--CA 1.491 2.332 0 C-N-CA 120.134 -1.031 . . . . 0.0 114.502 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.403 HG22 ' HB3' ' A' ' 26' ' ' ARG . 15.3 tt -105.98 138.35 19.63 Favored Pre-proline 0 N--CA 1.498 1.959 0 CA-C-O 119.333 -0.365 . . . . 0.0 110.625 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.499 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 3.3 Cg_endo . . . . . 0 C--N 1.316 -1.141 0 C-N-CA 121.472 1.448 . . . . 0.0 109.371 170.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 25' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -147.15 -89.01 0.08 OUTLIER Glycine 0 N--CA 1.483 1.779 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 176.04 -171.43 0.07 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 124.92 1.012 . . . . 0.0 112.215 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.5 m -45.71 147.24 0.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.7 m -108.78 25.89 11.21 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 111.003 -2.817 . . . . 0.0 110.832 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.8 t -83.48 -66.56 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 113.999 -1.455 . . . . 0.0 109.15 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 30.3 t-105 -59.34 -41.82 90.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 124.356 1.035 . . . . 0.0 109.975 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.4 tt -162.54 124.25 1.61 Allowed Pre-proline 0 N--CA 1.485 1.311 0 CA-C-N 113.562 -1.654 . . . . 0.0 108.417 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -67.71 148.33 77.43 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.24 1.96 . . . . 0.0 110.092 171.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.408 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 1.7 p -67.85 173.77 4.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 124.064 0.852 . . . . 0.0 111.67 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.09 -58.36 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.0 p -66.09 -56.98 8.77 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.998 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.2 -32.31 73.67 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.491 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.59 -26.65 33.75 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 123.499 0.499 . . . . 0.0 112.037 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.0 mt -70.24 -75.4 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 123.824 0.703 . . . . 0.0 109.885 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.58 -57.82 14.85 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -76.9 -171.93 2.13 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 114.068 -1.066 . . . . 0.0 109.455 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.5 t -146.57 153.43 40.35 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.427 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.408 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 1.2 m -103.05 104.5 14.68 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.94 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -137.25 140.38 41.6 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.369 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 47.58 63.88 1.82 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 124.485 1.115 . . . . 0.0 110.806 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 38.27 45.94 0.84 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 114.178 -1.374 . . . . 0.0 114.139 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.468 HG13 ' CG ' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -150.97 132.53 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.598 179.647 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 37.3 t -100.86 68.44 1.29 Allowed 'General case' 0 N--CA 1.506 2.375 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.492 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 14.9 m-30 -111.19 160.24 17.13 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.915 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.407 ' O ' HG22 ' A' ' 29' ' ' ILE . 3.6 tmt_? -103.15 69.53 1.02 Allowed 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 64.76 77.49 0.31 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 113.295 -1.775 . . . . 0.0 111.434 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.86 -18.4 1.91 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 116.732 1.453 . . . . 0.0 116.732 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 26' ' ' ARG . 5.8 tp -89.83 128.15 51.32 Favored Pre-proline 0 N--CA 1.499 2.009 0 CA-C-N 118.349 1.075 . . . . 0.0 109.893 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.492 ' HA ' ' CD1' ' A' ' 25' ' ' TYR . 10.1 Cg_endo . . . . . 0 N--CA 1.488 1.155 0 C-N-CA 122.032 1.821 . . . . 0.0 111.396 -175.378 . . . . . . . . 1 1 . 1 stop_ save_